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Obesity occurs when nutrient intake exceeds energy expenditure over prolonged 
periods. In the modern world, obesity has reached epidemic proportions. 
Complications of obesity, including cardiovascular disease, non-alcoholic fatty 
liver disease, certain forms of cancer, and metabolic dysfunction contribute 
substantially to morbidity and death today. With 13% of the world’s population 
affected, the rising rates of obesity will grow as a public health burden. Until 
recently, pharmacologic attempts to treat obesity have focused on reducing food 
intake. However, motivated in part by recent studies in mice and by analyses of 
fat in humans, approaches to increasing energy expenditure, specifically 
thermogenic energy expenditure, may provide a new therapeutic avenue.  
 
Most simplistically, there are two classes of adipocytes: storage and thermogenic. 
Storage fat, typically composed of unilocular white adipocytes function as storage 
depots for excess calories. On the other hand, thermogenic fat containing brown 
or beige adipocytes, generate heat through uncoupled mitochondrial respiration, 
This regulated generation of heat, known as thermogenesis, is used by organisms 
to maintain or increase body temperature. Historically, thermogenesis has been 
divided into shivering and nonshivering thermogenesis. Repeated, rapid 
contraction of skeletal muscles generate heat and is the basis for shivering 
thermogenesis. Nonshivering thermogenesis (NST) describes all the other 
mechanisms by which an organism can generate regulated heat. Only two 
organelles are known to contribute to NST: the mitochondrion of brown and 
beige adipocytes and the sarcoplasmic reticulum of muscle. The role of other 
organelles has not been systematically studied.  
 
Here we show in mice that thermogenic stimuli, including a cold challenge and 
pyrogenic molecules, activate a lysosomal program in a known thermogenic tissue 
(BAT) as well as several “non-thermogenic” organs, including the spleen, liver 
and skeletal muscle. A similar program is activated by a cold challenge in the 
metazoan, Drosophila melanogaster, suggesting an evolutionarily ancient origin 
for this response. We show by both pharmacologic and genetic means that 
impairment of lysosomal function compromises the thermogenic response of 
individual cells ex vivo and of mice in vivo. Data from genetic manipulations find 
that impairment of lysosome function leads to cold intolerance and death as well 
as modestly downregulate the classical Ucp1 thermogenic program. However, 
pharmacological inhibition reveals that impairment of lysosome function can 
compromise thermogenesis without altering the Ucp1 program.  
 
As part of our efforts to study lysosome function in thermogenesis, we developed 
a new method of measuring thermogenesis in primary cells. Using isothermal 
titration calorimetry (ITC), we quantitatively measured the heat generated by 
cells isolated from mice. This permitted us to assess the effects of both genetic 
and pharmacologic manipulations on the generation of heat and allowed us, for 
the first time, to measure the heat (uCal/sec/cell) of BAT in the basal and 
stimulated state. With ITC, we demonstrated that the impairment of lysosome 
function had direct effects on the generation of cellular heat, independent of 
systemic modulators of temperature such as basal metabolic rate or circulatory 
dissipation.  
 
From these studies, we conclude that lysosomes are thermogenic organelles 
induced by cold and pyrogenic stimuli and contribute both directly and indirectly 
to thermogenesis. Our work also suggests that lysosome thermogenesis may 
provide a means of thermoregulation in poikilotherms as well as in tissues 
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 1 
CHAPTER ONE  
INTRODUCTION 
The Obesity Epidemic 
 
The arc of human health and epidemiology has been marked by periodic abrupt 
and dramatic shifts. Large environmental changes, mass migrations, and  societal 
development skills such as agriculture and sewage systems, have rapidly changed 
the health of large populations. Complementarily, in the last century there has 
been an abrupt, precipitous decline in deaths from acute infectious diseases and a 
parallel rise in deaths from chronic disorders.  
 
The discovery of antibiotics and antisera, provided a means to treat most 
bacterial and many viral infections. In parallel, as the twentieth century 
progressed, the hunger and malnutrition that had once been widespread became 
no longer in developed countries. Instead, the converse – an abundance of 
inexpensive food –  became an unexpected source of a new epidemic. Ironically, 
our ingenious solutions to previous generations’ problems have given rise to a 
new unexpected problem: a curse of abundance, manifested in biological form as 
the obesity pandemic. 
 
In simplest terms, obesity can be reduced to a thermodynamic formula consisting 
of only two variables: energy intake and energy expenditure. When energy intake 
exceeds that of energy expenditure, the individual is in a state of negative energy 
balance, resulting in weight loss. However, when the latter exceeds that of the 
former, there is a state of positive energy balance, resulting in weight gain. The 
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chronic tipping of this energy scale towards weight gain can ultimately lead to 
obesity. Globalizing factors on culture and national developments have changed 
the feeding and exercise behaviors even in developing nations. Obesity is a public 
health challenge not only in the West, but also worldwide. 
 
Unfortunately, obesity is more than just a concern of body aesthetics; it also 
significantly contributes to morbidity and mortality. Currently 78.4 million 
(Ogden et al. 2014) individuals in the United States alone and an additional 600 
million worldwide (“WHO – Obesity and Overweight” 2016). Comorbidities of 
obesity include cardiovascular disease (Menke et al. 2007), diabetes (Ali H. 
Mokdad 2001)(A. H. Mokdad et al. 2000), non-alcoholic fatty liver disease (Peng 
et al. 2012; Watts et al. 2001; Chan et al. 2002), certain cancers (Richards and 
Lisa 2009; Magliano and Dianna 2013; Pendyala, Swaroop, and Peter 2008; 
Brown and Simpson 2013; L. Chen et al. 2016) and neurodegeneration (Sriram et 
al. 2002; Platt et al. 2016; Nuzzo et al. 2015; MacPherson et al. 2015; McGuire 
and Ishii 2016). Such consequences create a financial toll for both individuals and 
society at large. Therefore, while the obesity epidemic is easy to dismiss 
superficially, it has enormous and devastating consequences. 
 
One potential therapeutic avenue for the treatment of obesity is through 
activation brown adipose tissue (BAT). Brown fat and its functionally related 
beige congener are catabolic organs that can burn calories through heat 
production. Therefore, BAT has the potential to increase energy expenditure and 
alter the thermogenic equation in favor of weight loss. This possibility has led 
some to imagine that BAT driven energy expenditure can provide a therapeutic 
opportunity for treating or preventing obesity. The majority of research into 
brown adipose tissue has focused on its transcriptional regulation and less on its 
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cell biology and molecular mechanisms, particularly of heat generation. This 
dissertation explores some aspects of the cellular and molecular mechanisms of 
heat generation by examining an organelle that has never been associated with 
thermogenesis until just recently (Martinez-Lopez et al. 2016). Our studies of the 
lysosome reveal a critical role for its function in homeothermy. Our findings offer 
potential new avenues for understanding brown adipose tissue and new 
approaches to develop therapies for obesity and related metabolic diseases. 
 
Therapeutic Interventions  
 
The remarkably high prevalence of obesity worldwide provides a strong incentive 
to find viable treatments. Pharmaceuticals have invested billions in obesity 
research to date. A large portion of the budget of NIH NIDDK funds the field. 
Yet, even in the face of such financial and temporal investment, outside of the 
invasive and expensive bariatric surgical options (Wolfe, Kvach, and Eckel 2016), 
simple, safe, and viable treatments still elude us, making obesity one of the most 
notoriously complex and difficult disease models to study and to treat.  
 
The comorbidities of obesity are numerous; as a result, obese patients are 
frequently placed under strict pharmacological regimens, either prophylactically 
or correctively. Nonetheless, this treatment philosophy inherently only targets the 
peripheral consequences of extraordinary weight gain and not the phenomenon 
itself. This unfortunate reality is due in part to the lack of effective prescription 
drugs for weight loss. Current safe options generally target energy intake and 
allow patients to lose on average, an unsatisfying 5-10% of their body weight over 
one year when used in conjunction with difficult lifestyle interventions such as 
diet and exercise (Nicklas et al. 2012); (Wing and Phelan 2005; Dombrowski et 
al. 2014). Even with modest changes in weight loss, side effects from such drugs 
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often make compliance difficult. Orlistat, an over-the-counter drug that prevents 
lipid absorption, results in uncomfortable and socially awkward digestive side 
effects(Cavaliere, Floriano, and Medeiros-Neto 2001). Appetite suppressants such 
as phentermine or desoxgen, methamphetamines, alter the central nervous system 
and result in sympathetic effects that exacerbate cardiovascular disease risk 
(Yosefy, Chaim, and Ronen 2010; Marks et al. 2016; Paratz, Cunningham, and 
MacIsaac 2016). Ultimately, these pharmacotherapies target only one variable of 
the energy homeostasis equation: energy intake, a characteristic clearly unfeasible 
for longterm effective weightloss.  
 
In the most dire cases, bariatric surgery becomes a potential option for patients. 
This option is often considered to be of last resort, only for patients with morbid 
obesity (BMI ≥ 40) who fail to lose weight even after strict dieting, exercise, and 
pharmacological support (Wolfe, Kvach, and Eckel 2016). Bariatric surgery 
comes in several forms: gastric band, gastric sleeve, roux-en-y gastric bypass, and 
biliopancreatic diversion with duodenal switch (J. Lee et al. 2016)(Hess 2007). 
Given the invasive nature of these surgeries, the usual surgical risks are involved; 
the estimated mortality post surgery is around 0.5-2%(Hess 2007; Flum and 
Patchen Dellinger 2004), alarmingly high for a preventable disorder. Nutritional 
deprivation and inadequacies are frequent among postoperative patients (Gletsu-
Miller and Wright 2013; O’Donnell and Kelly 2006; Shankar, Boylan, and Sriram 
2010). Sudden changes in diet and nutrition also lead to increased risk for bone 
loss (Casagrande et al. 2012; Lemke et al. 2013). Long term weight loss from 
bariatric surgery ranges from 15-40% from total body weight, indicating its 
efficacy (Mahawar et al. 2015; Topart et al. 2012; Courcoulas et al. 2013). 
Nonetheless, given the previously enumerated risks as well as prerequisites for 




Therefore, increasing energy expenditure safely via a pill, colloquially known as 
the diet pill, would be the holy grail for metabolic interventions. Currently, 
patients can address this variable through exercise, but maintaining compliance 
represents a substantial challenge. The discovery of active brown adipose tissue 
in humans (Jan Nedergaard, Bengtsson, and Cannon 2007; Saito et al. 2009; 
Virtanen et al. 2009; van Marken Lichtenbelt et al. 2009) has provided a new 
strategy to develop anti-obesity pharmacotherapies. Nonetheless, the amount of 
brown adipose tissue in humans, inducible or not, can be so marginal that the 
amount it can contribute to energy expenditure is dubious. This dissertation 
proposes a novel way of increasing energy expenditure that can target cell types 




While the clinical and biomedical implications of this dissertation applies to 
obesity and metabolism, it is ultimately on the study of cellular thermogenic 
regulations and principles. As the focus of thermodynamics is on energy and 
matter transfer, the field provides the physical properties that explain metabolic 
phenomena. Therefore, thermogenesis and its metabolic benefits ultimately relies 




Thermodynamics is the study of energy transfer in relation to a system. 
Historically, the term was coined around 1840 from the Greek words therme, 
“heat,” and dynamis, “power.” Likewise, for most of its research lifetime, the field 
focused on the effects of heat and work due to its relationship with the 
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development of engines at the time. A macroscopic science, thermodynamics 
focuses only on a few variables and does not concern itself with microscopic 
behaviors of its components.  
 
In thermodynamics, there are several key definitions and physical entities: 
system, state, equilibrium, and process. The “system” is a finite, bounded 
quantity of matter, and everything exterior of the boundary is known as the 
“surroundings.” A closed system is a specific class of system where matter is 
incapable of crossing the boundary, allowing for conservation of mass to be 
satisfied. The “state” of the system is a set of measurable properties defined when 
a system is in equilibrium. Therefore, when the state of a system is unchanged, 
then the system is in equilibrium. Equilibrium can be mechanical, thermal, and 
chemical. Finally, when the equilibrium is disrupted and the state of the system 
changes, then a “process” is occurring. All processes are irreversible to some 
degree, a phenomenon known as inefficiency. 
 
Laws of thermodynamics 
In thermodynamics, there are four defining laws that characterize all 
thermodynamic systems.  
 
Zeroth law of thermodynamics 
The zeroth law of thermodynamics states that if two distinct systems are in 
thermal equilibrium with a third distinct system, than the two systems are also 
in thermal equilibrium with each other. With this characterization, the law allows 
for for an equivalence relation and was expressed in more physically meaningful 




First law of thermodynamics 
The first law of thermodynamics, also known as the law of energy conservation, 
states that changes in the internal energy of a closed system must be equal to the 
difference between the energy applied and performed by the system. Therefore, a 
perpetual motion machine is impossible. Further, the law of conservation of 
energy suggests that energy can neither be created nor destroyed, but can change 
forms, the fundamental concept behind uncoupled thermogenesis by UCP1. 
 
Second law of thermodynamics 
The second law of thermodynamics is an empirical principle asserting that 
entropy is always positive. As a result, all processes must be irreversible to some 
extent as energy will dissipate. 
 
The conception of the second law came out of disparities between the theoretical 
implications of the first law and actual observed thermodynamic events. While 
the first law provides symmetry between the initial and final states of an evolving 
system, it fails to explain how natural processes seem to prefer a specific state. 
By establishing the notion of “entropy,” the second law allows the final state to 
be of lower energy, and hence preferred, over the initial state of higher energy. 
The second law does not violate the first law, as the differential energy between 
the initial and final states has simply dissipated. As such, the overall energy of 
the system still conserved. 
 
Third law of thermodynamics 
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The final and third law of thermodynamics argues that the entropy of a system 
at absolute zero is a constant. This law allows for a reference point for entropy 
and known as the Boltzmann’s constant.  
 
Biological thermodynamics 
Energy is required for all life and serves as the fundamental basis for chemical 
reactions, and hence biological reactions. The core principles of thermodynamics 
in biological systems that will be discussed in this chapter rely primarily on the 
first and second laws of thermodynamics. 
 
Biological thermodynamics study primarily the various biological dynamics 
within the organisms and cells. Therefore, the applicability of thermodynamics 
extend far beyond that of its original purpose for engines and machinery. As 
stated by Einstein in his autobiography: 
 
“A theory is the more impressive the greater the simplicity of its premises is, the more different 
kinds of things it relates, and the more extended its area of applicability. Therefore the deep 
impression which classical thermodynamics made upon me. It is the only physical theory of 
universal content concerning which I am convinced that, within the framework of the 
applicability of its basic concepts, it will never be overthrown.”  
 
Indeed, this framework is of particular importance to this dissertation as it 
attempts to use its foundations to describe a novel feature of lysosomal biology as 







Brown Adipose Tissue 
 
The brown adipocyte: the only known cell devoted to regulating the host 
organism’s body heat, a necessity for and unique quality of homeotherms. A 
century ago, this tissue was oddly known as the “hibernation gland;” today, it is 
lauded as the “good fat,” creating a false dichotomy of physiological values on fat 
depots when in fact the lack of “bad” white adipose tissue leads to profound 
metabolic disturbances in lipid and glucose homeostasis. 
 
The evolution of our knowledge of the brown adipocyte has progressed at a slow 
pace. While the tissue was first discovered in 1551 by German physician and 
botanist Konrad Gesner (Gessner, Conrad, and Burndy 1551), it took another 
400 years before BAT was dubbed the “hibernation gland” (Sheldon 1924) for its 
role in torpor, a physiological state of reduced body temperature and metabolic 
rate (Davenport and John 1992; Staples 2016). An additional forty years 
proceeded before researchers postulated that the tissue produced heat (Smith and 
Hock 1963; Cameron and Smith 1964; Smith 1964). Nearly twenty years later, 
the uncoupling of mitochondrial H+ gradient by the Uncoupling Protein 1 
(UCP1) was at last identified, cloned, and suggested to be responsible for 
thermogenic ability of brown adipocytes (Nicholls, Bernson, and Heaton 1978). 
The study of brown adipocytes remained an area of active research but were 
assumed to be irrelevant to adult humans (Jan Nedergaard, Bengtsson, and 
Cannon 2007). However, about a decade ago, a series of studies (Christensen, 
Clark, and Morton 2006; Garcia et al. 2006; Garcia et al. 2004; Heiba et al. 2005; 
Jacobsson et al. 2005; Sturkenboom et al. 2004; Virtanen et al. 2009; van Marken 
Lichtenbelt et al. 2009; Saito et al. 2009) showed that brown adipocytes indeed 
exist in adult humans. This revelation was then supported by the discovery of 
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the “beige/brite” adipocyte, an inducible thermogenic cell similar to the brown 
adipocyte in function (Seale et al. 2008; S. Cinti 2002; Himms-Hagen et al. 2000; 
Wu et al. 2012; Petrovic et al. 2010) that exists in humans (Bartesaghi et al. 
2015; P. Lee et al. 2014; Lidell et al. 2013). For many, these discoveries unleashed 
a fervor of excitement - activation of these thermogenic adipocytes to alter 
thermodynamic balance could induce weight loss and allow for a viable anti-




While energy is essential for life and is often in limited supply, reducing its 
efficiency may be beneficial in a limited set of circumstances. Biological systems 
function in a specific temperature range beyond which life becomes impossible 
and in a narrower range in which biological reactions are most efficient. 
Organisms maintain this temperature range compatible with both life and 
optimal biological function through heat generation and exchange, preventing the 
hazardous effects of  large environmental temperature variations. Although 
ectotherms rely primarily on external sources of heat, endotherms draw on 
internal sources - primarily, thermogenesis. This latter phenomenon, 
thermogenesis, is the core of brown adipose tissue biology. 
 
Most biological reactions generate small amounts of heat due to inherent 
inefficiencies as a result of second law of thermodynamics. So called biological 
“futile cycles” take advantage of this, by undergoing chemical transformations 
that end in the same chemical states they began (Qian and Beard 2006). Such 
processes therefore dissipate enthalpy and generate heat, contributing to the 
overall thermogenic output of an organism (Tseng et al. 2010; Rolfe and Brown 
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1997). There are several known examples of regulated futile cycles: 
transmembrane ion leaks, muscle/actin-myosin relaxation through SERCA, and 
triglyceride/fatty-acid cycling (Tseng et al. 2010). The best studied regulated 
thermogenic process is the “uncoupling” of the inner mitochondrial membrane 
through the actions of Uncoupling Protein 1 (UCP1), a phenomenon usually 
categorized as “nonshivering” thermogenesis (NST).  
 
UCP1, a small protein of 32 kDa, is unique to thermogenic adipocytes and is 
dependent on mitochondrial biology. The protein is expressed exclusively in the 
inner mitochondrial membrane where substrates such as ADP, ATP, phosphate, 
oxoglutarate, citrate, glutamate, and malate are transported (Wohlrab and 
Hartmut 2009; Krämer and Klingenberg 1977). The inner membrane is the site 
for ATP production by oxidative phosphorylation (Berg, Tymoczko, and Stryer 
2002). The endergonic production of useful chemical energy is coupled to the 
exergonic process of electron flow generated by the electron transport chain. This 
flow of electrons creates an uneven distribution of H+ protons in the 
intermembrane space, thereby generating an electrochemical gradient (Berg, 
Tymoczko, and Stryer 2002). Chemiosis requires the protons to move down its 
electrochemical gradient across the inner membrane (Mitchell and Moyle 1967). 
In the mitochondria of most cells, chemiosis can only occur through ATP-
synthase, where ATP is generated when the protons flow into the mitochondrial 
matrix (Berg, Tymoczko, and Stryer 2002; Schultz and Chan 2001).  
 
UCP1 functions by disrupting the transmembranal electrochemical gradient 
established by the mitochondrial electron transport chain (Nicholls, Bernson, and 
Heaton 1978). As a result, the protons in the intermembrane space can bypass 
the ATPase pump and flow down the gradient without synthesizing ATP. 
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Energy that would have been converted to useful chemical energy, or ATP, is 
instead dissipated as heat, as dictated by first law of thermodynamics (Nicholls 
and Locke 1984). As a proton transporter, UCP1 shares a similar tripartite 
structure with other mitochondrial carriers, but has unique matrix facing and C-
terminus sites that likely confer UCP1’s function (Klingenberg, Martin, and Shu-
Gui 1999; J. Nedergaard et al. 2001). While UCP1 is part of a larger UCP family 
that also includes both UCP2 and UCP3, presence of UCP1 is necessary for this 
uncoupling mechanism; neither UCP2 nor UCP3 are capable of the uncoupling 
mechanism of UCP1 (Matthias et al. 2000).  
 
While the brown adipocyte is not unique in its thermogenic abilities, its 
expression of UCP1 allows it to be only known cell devoted to heat generation 
and is central to nonshivering thermogenesis. NST is the most well known 
mammalian process that creates heat to maintain body temperature in the face of 
a cold challenge. 
 
During cold exposure, temperature sensitive neurons in the skin (McKemy, 
Neuhausser, and Julius 2002; Peier et al. 2002; Bautista et al. 2007; H. Lee et al. 
2005; Moqrich et al. 2005) as well as peripheral (Riedel 1976; Gupta, Nier, and 
Hensel 1979) and central thermoreceptors (Guieu and Hardy 1970; Tominaga et 
al. 1998; Bautista et al. 2007) on internal organs signal to the hypothalamus, 
activating the adrenal glands to secrete norepinephrine and epinephrine(Caldwell, 
Graves, and Wallace 1995). Simultaneously, these catecholamines are released 
locally by the neurons innervating the brown adipose tissue (Wirsén 2011; 
Bargmann, von Hehn, and Lindner 1968; Murano et al. 2009). The 𝛽-adrenergic 
receptors and 𝛼-1-adrenergic receptor on the membrane of brown adipocytes are 
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thereby activated (Svartengren 1982; Kurahashi, Masashi, and Akihiro 1979; 
Horwitz and Hamilton 1984). These adrenergic receptors are coupled to Gs-
proteins and activate adenylate cyclase upon stimulation(Gal et al. 1984; Levitzki 
and Alexander 1976; Milde et al. 2014). The resultant increase in cyclic adenosine 
monophosphate (cAMP) levels by adenylate cyclase activates protein kinase A 
(PKA). PKA then proceeds to promote NST through three signaling pathways: 
perilipin (PLIN1), p38 mitogen-activated protein kinase (p38 MAPK), and cAMP 
response element binding-protein (CREB) (Collins 2011; Cao et al. 2004; Bartelt 
and Heeren 2012). CREB and phospho-p38 MAPK work together to generate 
UCP1 production and action in the mitochondria. Together, they activate the 
transcriptional machinery including transcription factor 2 (ATF2)(Cao et al. 
2004), zinc finger protein 516 (ZFP516)(Dempersmier et al. 2015), peroxisome 
proliferator-activated receptor gamma coactivator 1-𝛼 (PGC1𝛼)(Cao et al. 2004), 
PR domain containing 16 (PRDM16)(Dempersmier et al. 2015), peroxisome 
proliferator-activated receptor 𝛼 (PPAR𝛼), peroxisome proliferator-activated 
receptor gamma (PPARgamma) and the retinoid x receptor (RXR)(Collins 2011; 
Bartelt and Heeren 2012). Once formed, the transcriptional complex drives 
factors that activate UCP1 transcription, translation, and insertion into the 
mitochondrial inner membrane (Figure 1.1)(Yubero et al. 1998; Hondares et al. 



















This same PKA dependent signaling cascade also induces perilipin dependent 
activation of neutral lipolysis in adipocytes, generating fatty acids – potential 
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substrates for UCP1 uncoupled oxidation (Miyoshi et al. 2006; Granneman et al. 
2009; Subramanian et al. 2004). It has been assumed that lipid stored in brown 
adipocytes then serves as a primary substrate for uncoupled thermogenesis 
(Calderon-Dominguez et al. 2015).  
Fatty acids and Thermogenesis 
 
Fatty acids are carboxylic acids with an aliphatic chain of varying lengths; these 
chains confer unique cellular properties. When metabolized via beta oxidation, 
fatty acids, per mole, yield as much as 129 ATP for the cell. Consequently, 
oxidation of fatty acids become the main source of “fuel” for thermogenesis. 
There are four different sources of fatty acids: 1) De novo synthesis by fatty acid 
synthetase, 2) localized hydrolysis of lipoproteins by extracellular lipase, i.e., 
lipoprotein lipase, 3) free fatty acid uptake from the circulation, and finally 4) 
lipolysis of intracellular lipid droplets by neutral lipases (Calderon-Dominguez et 
al. 2015). Current dogma suggests that lipolysis of lipid droplet triglycerides via 
adipose triglyceride lipase (ATGL/PNPLA2/Desnutrin), and regulated by 
adrenergic pathways is the primary source of fuel for brown adipocyte 
thermogenesis (Morak et al. 2012; Ahmadian et al. 2011; Cannon and Nedergaard 
2004). The initial studies I undertook were designed to test whether the neutral 
lipase ATGL is necessary for NST, and whether acid lipolysis via lysosomal acid 
lipase (LIPA) could play a significant role.  
 
Fatty acids, however, serve as more than just fuel for mitochondrial oxidation. 
Both fatty acids (Shabalina et al. 2008) and purine nucleotides (Rial and 
González-Barroso 2001; Shabalina et al. 2004) interact with UCP1 to enhance its 
uncoupling capabilities. Several laboratories have proposed a number of potential 
mechanisms. One model posits that the fatty acid localizes to binding sites in the 
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proton conduction channel of UCP1, where their acidic moeities serve as a bridge 
for protons to pass through the membrane (Winkler and Klingenberg 1994). 
Another potential mechanism imagines fatty acids as proton shuttles, with the 
UCP1 protein catalyzing the necessary steps (Garlid, Jabůrek, and Jezek 1998; 
Fedorenko, Lishko, and Kirichok 2012). Fatty acids have also been conjectured to 
compete with purine nucleotides at either an activating or allosteric site on 
UCP1, thereby altering its protonophoric properties via structural changes (Rial 
and González-Barroso 2001).  
 
Although the mechanism by which fatty acids facilitate UCP1-dependent 
thermogenesis is unclear, these findings point to fatty acids as signaling molecules 
in addition to substrates for NST.  
 
 
Cellular Biology of Brown Adipose Tissue 
 
Brown adipocytes differ from their white counterparts in several qualities other 
than their expression of UCP1. The defining features of brown versus white 
adipocytes are lipid droplet morphology and mitochondrial number. White 
adipocytes contain unilocular droplets that occupy over 90% of the volume of 
each cell, pushing other organelles to the plasma membrane. Brown adipocytes, 
on the other hand, have multilocular lipid droplets surrounded by large numbers 
of mitochondria that give brown adipocyte their eponymous color. Additionally, 
BAT depots, compared to white adipose tissue (WAT) depots, are highly 
innervated and vascularized, characteristics that can facilitate thermogenesis 





BAT depots are also located in anatomically distinct locations: WAT depots are 
found under the dermis (subcutaneous)(Saverio Cinti and Saverio 2001; S. Cinti 
2012), surrounding visceral organs regions (visceral)(Saverio Cinti and Saverio 
2001; S. Cinti 2012), between muscle fibers (muscular) (Gallagher et al. 2005), 
and around blood vessels (vascular) (Gu and Xu 2013); classical BAT areas are 
located in the interscapular, cervical, periaortic sites in rodents and may be found 
in cervical-supraclavicular, periaortic, and perirenal regions in humans - although 
these regions are vary among individuals and age (Sacks and Symonds 2013; 
Cypess et al. 2015; Cypess and Kahn 2010; Sidossis and Kajimura 2015).  
 
In the last decade, it has become apparent that a separate and distinct class of 
thermogenic adipocytes exists and is developmentally and anatomically distinct 
from classical brown adipocytes (Wu et al. 2012). These “beige” (also called 
“brite”) thermogenic adipocytes are found within WAT depots and detectable 
after activation by cold exposure or catecholamine induction (Wu, Cohen, and 
Spiegelman 2013). Beige adipocytes have a remarkable transformative ability: At 
thermoneutrality, they express little UCP1, relatively few mitochondria, and 
contain unilocular lipid droplets; following adrenergic stimulation, these cells 
increase UCP1 expression, mitochondrial numbers, and thermogenesis(Wu, 
Cohen, and Spiegelman 2013). As a consequence, these adipocytes seem to exhibit 
intermediate features, such as paucilocular droplets and a few mitochondria, 
giving the adipocytes the name “beige” as a description of the color between 
white and brown (Wu, Cohen, and Spiegelman 2013; Giralt and Villarroya 2013; 
S. Cinti 2012).  
 
Classical brown adipocytes are more closely related to muscle cells (myocytes), 
than to beige or white adipocytes, while beige adipocytes are more closely related 
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to white adipocytes than brown adipocytes. Both myocytes and brown adipocytes 
are derived from myogenic factor 5 (myf5) expressing precursors, while white and 
beige adipocytes, from myf5 non-expressing cells (Sanchez-Gurmaches et al. 2012; 
Seale et al. 2008). This surprising distinction between not only brown and white 
adipocytes, but also two supposedly functionally similar cells, brown and beige 
adipocytes, extends beyond their ontogeny. Both thermogenic adipocytes exhibit 
their own individual transcriptional profiles and gene signatures (Sanchez-
Gurmaches and Guertin 2014). Using data profiling of these two cell types, 
researchers have only begun to examine the types of thermogenic cells in humans 
in order to understand their therapeutic utility (Seale, Kajimura, and Spiegelman 
2009). 
 
Therapeutic Utility of Brown Adipocytes 
 
Initial demonstrations of BAT existence in humans were done via 18-fluoro-
deoxyglucose uptake assays, detected by positron emission tomography/computed 
tomography (PET/CT) in individuals after cold exposure (Virtanen et al. 2009; 
Saito et al. 2009; Zingaretti et al. 2009; van Marken Lichtenbelt et al. 2009; 
Cypess and Kahn 2010). These demonstrations had scientists scrambling to 
elucidate the mysteries of thermogenic adipocytes in attempts to find a viable 
anti-obesity therapy.  
 
More significantly however, human BAT is metabolically active and may 
contribute a significant portion to overall energy expenditure when activated. 
Ouellet, et. al., showed that a short three hour cold exposure led to an increase of 
80% in basal metabolic rates, partly as a consequence of BAT activation 
(Ouellet, Véronique, et al. 2012). Further, this activation may increase lipid 
uptake from lipolysis and lipoproteins, potentially improving overall metabolic 
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profiles in the long term. Along the same lines, human data support a correlation 
between UCP1 expression and circulating serum TG and HDL (Chechi et al. 
2013). Such observations support the potential therapeutic power of thermogenic 
adipocyte activation. 
 
Nonetheless, new findings show that this optimism may be misplaced. Although 
it is clear that BAT in humans exist and may even contribute to basal 
metabolism when activated, the extent in which we can utilize BAT’s energy 
expending abilities as a workable therapy for treating obesity is a question yet to 
be answered. There are many reasons to doubt its utility: calculations attempting 
to determine the contribution of BAT to weight loss estimate that 50 grams or 
more of active BAT is necessary to burn a modest 125 kcal/day in humans 
(Rothwell and Stock 1979). Additional studies have further supported this 
calculation, with estimates as low as 8 kcal/day (Ouellet, Labbé, et al. 2012). 
Even more discouragingly, given the tight central control over energy homeostasis 
in the body, it seems that an increase in expenditure by BAT would only be 
counteracted by orexigenic behavior initiated by the brain (Tam, Lecoultre, and 
Ravussin 2012). Nonetheless, researchers are still hopeful that BAT could be a 
weight loss maintenance option at minimum. 
 
Introduction to Lysosomes 
 
Discovered serendipitously in 1955 by Christian de Duve (de Duve et al. 1955), 
the Belgian cytologist, lysosomes have often been relegated to the undignified role 
as the “garbage disposal of the cell”. De Duve himself described the lysosome as 
“a saclike structure surrounded by a membrane and containing acid 
phosphatase.” Furthering the imagery, he christened his new discovery with the 
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name, “lysosome,” a portmanteau of the Greek words, lysis, “to loosen,” and 
soma, “the body.”(de Duve et al. 1955; Castro-Obregón 2010; Nicholls, Bernson, 
and Heaton 1978) The connotations stuck, for decades the lysosome was thought 
of nothing more than a vesicle of digestive enzymes. This simplistic, unglorified 
view was only recently given way as new evidence emerged that paints the 
lysosome as a dynamic organelle that is more than a digestive sac. Rather, it is 
major regulatory body critical to multiple cellular functions and a key the cell’s 




Like all cellular vesicles, the lysosome is a single lipid bilayer membrane bound 
organelle. However, this generalized description far from captures the nuanced 
complexity of this critical organelle. These complexities come in large part from 
the inherent degradative nature of the lysosome. One of the lysosomal 
membrane’s primary functions is to protect the cell from the lysosome’s acidic 
contents. A thick polysaccharide based coating, known as a glycocalyx, coats the 
lumenal side of the lysosomal membrane(Carroll and Mark 1989; Kolsen-Petersen 
2015). This coating likely protects the membrane from degradation by the 
various hydrolases and low pH level (Carmine Settembre, Carmine, Alessandro, 
et al. 2013).  
 
In addition to this protective component, an estimated 50 or more proteins reside 
on the lysosomal membrane, more than the average cellular vesicle (Schröder et 
al. 2007). The lysosomal membrane proteins available fall into six different 
functional categories: structural, ion channels, transporters, catabolic, trafficking, 
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and nutrient sensing (Callahan, Bagshaw, and Mahuran 2009; Schröder et al. 
2007).  
 
Lysosomes, along with late endosomes, maintain a low, acidic pH. The unusual 
pH of this organelle is maintained by the ion channel, chloride ion channel 7 
(CLC7) (Graves et al. 2008; Kasper et al. 2005; Weinert et al. 2010) and the 
vacoular-type H+-ATPase (V-ATPase) pump (Ohkuma, Moriyama, and Takano 
1982), which pump chloride out of and protons into the lysosomal lumen, 
respectively. With these two proteins, along with the help of cation transporters 
mucolipin (MCOLN1/TRPML1) (F. Zhang et al. 2009; F. Zhang et al. 2011) and 
two pore calcium channels 1 and 2 (TPC1 and TPC2) (Calcraft et al. 2009), 
negative charges are moved out of the vesicle, while positive charges are moved 
in(Mindell 2012). The resultant acidic environment then becomes home to an 
estimated 60-70 known acid hydrolases. These degradative enzymes function best 
at a low pH and become significantly less active in the neutral pH of the cytosol. 
As a consequence, degradation of macromolecules by these powerful enzymes is 
limited within the lysosome.  
 
The hydrolases are responsible for the degradative function of lysosomes. Among 
these proteins are glycosidases, lipases, nucleases, sulphatases, and peptidases, all 
necessary to breakdown the breadth of substrates: proteins, glycogen, lipids, and 
glycosaminoglycans (Carmine Settembre, Carmine, Alessandro, et al. 2013). In 
humans, functional mutations in any of these hydrolases result in some form of 
lysosomal storage disease each associated with characteristic phenotypes that 
sometimes result in premature morbidity (Vellodi 2005). The golgi apparatus 
modifies the enzymes with mannose-6-phosphate, allowing the enzymes to not 
only traffic to the lysosome, but also become secreted and taken up by other 
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cells, a complicating factor that needs to be considered when generating tissue 
specific animal models (Braulke, Thomas, and Bonifacino 2009; Ghosh, Dahms, 
and Kornfeld 2003). This phenomenon is the basis of enzyme replacement 
therapy for sufferers of lysosomal storage diseases (Neufeld 1980). 
 
The defining function of lysosomes is the degradation of a wide variety of 
macromolecules. Unlike other degradative machinery in the cell (i.e., 
proteasomes), the lysosome degrade molecules and entire cellular structures, 
organelles, molecules derived from multiple cellular compartments, and even 
exogenously derived molecules (Ballabio 2016). Targeting of molecular and 
cellular components to lysosomes is tightly regulated and dependent on a large 
number of proteins. Nearly twenty various proteins have been implicated in these 
functions, mostly Soluble NSF Attachment Protein Receptor (SNARE) proteins 
(Pryor et al. 2004; Weber et al. 1998; Jahn and Scheller 2006) and Ras-related 
protein (RAB) GTPases (Zerial and McBride 2001; Rink et al. 2005; Ohya et al. 
2009). RAB5 and RAB7 mediate the endolysosomal pathway, giving the cell the 
ability to take in various proteins and cellular substrates from outside the cell 
(Rojas et al. 2008; Wang et al. 2011; Zeigerer et al. 2012). SNAREs, in addition 
to driving endosome fusion with lysosomes, also engage in autophagosome-
lysosome fusion required for functional autophagy (Itakura, Kishi-Itakura, and 
Mizushima 2012).  
 
Trafficking events often result in intralysosomal vesicles which arise from 
lysosomal invagination. Degradation of the intralysosomal membranes is a 
curiosity as the lysosome must be able to selectively recognize intralysosomal 
membranes from the native lysosome membrane. These vesicles contain 
additional proteins that hydrolyze lipids and were discovered primarily through 




Overview of Lysosomal Functions 
 
The various lysosomal functions can be categorized into three groups in: (1) 
degradation, (2) secretion, and (3) signalling (Figure 1.2).  
 
 
Figure 1.2: Overview of the various functions of the lysosome. 
Degradation 
As with any cellular process that requires trafficking, but particularly for an 
organelle that handles such large fluxes, the process requires precision in spite of 
its complexity. The eukaryotic cells have unique routes specific to the cargo type. 
Cargo can be both intra- and extracellular derived, the latter generally entering 
lysosomes through endocytosis. Endocytosis involves the creation of endosomes, 
which are among the main characters of lysosomal mediated degradations(J. P. 
Luzio et al. 2000). While endocytosis is often limited to receptor-mediated 
endocytosis, lysosomes are involved in the degradation of cargo from 
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phagocytosis, macropinocytosis, clathrin mediated endocytosis, and clathrin 
independent endocytosis (Conner and Schmid 2003; Doherty and McMahon 2009; 
Hansen and Nichols 2009; Sorkin and von Zastrow 2009).  
 
Phagocytosis describes cellular phenomenon of vesicular internalization of solid 
particles, including bacteria. The immune system, particularly macrophages, use 
phagocytosis as part of an organism’s immune defense strategy (Rosales 2008). 
When liquids are internalized, the process is known instead as macro/pinocytosis 
(LaBella 1973). Clathrin mediated endocytosis is the most understood route of 
endocytosis that is mediated by the protein, clathrin (Kirchhausen, Owen, and 
Harrison 2014). This molecule helps form the coated pit in the lumenal side of 
plasma membrane that buds to form a clathrin-coated vesicle. As a consequence 
of its actions, the vesicle includes not only the endocytosed material, but also 
extracellular fluid (Benmerah, Alexandre, and Christophe 2007; Rappoport 2008). 
On the other hand, endocytosis can also occur independent of clathrin, which can 
form caveolae or polymorphous tubes to engulf extracellular material (Hansen 
and Nichols 2009). Nonetheless, while the starting fates of these vesicles differ, 
their final fates all end at the lysosome.  
 
Once the cargo is trapped within the endosome, the endosome moves to deliver 
the contents to the lysosome, along the endolysosomal pathway (Sorkin and von 
Zastrow 2009). Aspects of this pathway are incompletely defined and several 
remain controversial, with models proposing either a maturation of the endosome 
to the lysosome or a fusion between the endosome and the lysosome. In both 
models, one of the necessary steps for endolysosomal pathway is the acidification 
of the vesicular lumen, to a pH of approximately 5 (Ohkuma and Poole 1978). In 
comparison, a true lysosome will have a lumenal pH of 4.5-5 (Mindell 2012). The 
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pH drop is necessary for the delivery of acid hydrolases by mannose-6-phosphate 
receptor (M6PR) into the endosomal lumen (J. Paul Luzio et al. 2007). To 
achieve the right pH levels, v-ATPase, Clc7, mucolipin 1 (MCOLN1 or 
TRPML1), two pore calcium channel 1 (TPC1) and 2 (TPC2) pump protons, 
transport cation into and anions out of the maturing endolysosomal lumen (see 
previous section, “Lysosome structure”). Once all the hydrolases and the various 
membrane proteins are delivered to the developing endolysosome, the vesicle 
matures into the lysosome and loses expression of M6PR (J. Paul Luzio et al. 
2007). 
 
Intracellular cargo can be delivered to the lysosome through a process known as 
autophagy. Autophagy can be additionally categorized to three groups: 
microautophagy, chaperone-mediated autophagy (CMA), and most famously in 
mammalian cells, macroautophagy. Microautophagy, most commonly found in 
prokaryotic cells, describes the cellular phenomenon of direct consumption of 
proteins by the lysosome (Mijaljica, Prescott, and Devenish 2011). CMA is far 
more selective, where proteins need to be transported to the lysosome with the 
help of a chaperone. Here, the transported protein requires unfolding in order to 
get through the lysosomal membrane through the help of lysosome-associated 
membrane protein 2A (LAMP2A)(Sahu et al. 2011; A. M. Cuervo and Dice 
1996). Mutations in this gene results in a lysosomal storage disorder known as 
Danon Disease, which disproportionately affects striated muscles, resulting in 
severe muscle weakness and early mortality (Rowland et al. 2016). Finally, 
macroautophagy, herein referred to as autophagy, uses an additional vesicle 
known as the autophagosome, a double membrane bound organelle that is 
capable of sequestering cytoplasmic material before fusing with lysosomes (He 
and Klionsky 2009; Noda and Inagaki 2015). In a way, autophagosomes resemble 
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that of the endosome, only designed for intracellular rather than extracellular 
cargo delivery.  
 
Secretion 
Lysosome-mediated exocytosis describes the specialized secretion of selective 
lysosomal contents into the extracellular environment. Although less studied than 
other functions of the lysosome, this mechanism is important in the bulk delivery 
of cargo and can be found in all cells (Rodríguez et al. 1997; Chavez, Miller, and 
Moore 1996; Coorssen, Schmitt, and Almers 1996; J. C. Stinchcombe and 
Griffiths 1999; N. W. Andrews 2000; Jaiswal, Andrews, and Simon 2002). 
Lysosomal exocytosis is particularly important in immune cell defense (Logan, 
Odemuyiwa, and Moqbel 2003; Wesolowski and Paumet 2011), bone remodeling 
(Mostov and Werb 1997), cell communication (Shin, Lee, and Jung 2012), 
pigmentation (J. Stinchcombe, Bossi, and Griffiths 2004), and plasma membrane 
repair (Castro-Gomes et al. 2016).  
 
Calcium concentration is the central determinant of lysosomal secretory behavior. 
Increases in intracellular calcium triggers exocytosis of lysosomes. Proteins 
involved include VAMP7, a vesicle SNARE protein, SNAP23, a target SNARE, 
the calcium sensor synaptotagmin VII (SYTVII), syntaxin 4, and RAB proteins 
(Rao et al. 2004; Jahn and Scheller 2006; Bossi and Griffiths 2005). Additionally, 
the calcium channel MCOLN1 (or TRPML1, transient receptor potential cation 
channel) regulates at least a subset of lysosomal exocytosis events (LaPlante et 
al. 2006). Other potential regulators of this phenomenon may also include 
autophagy proteins: Microtubule-associated protein light chain 3 (LC3) is 
essential for lysosomal secretion by allowing the lysosome to fuse with the plasma 
membrane. Nonetheless, although LC3 is classically seen as an autophagy protein, 
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autophagy itself may not be involved in the direction of lysosomal secretion 
(DeSelm et al. 2011).  
 
One of the key features of lysosome-mediated exocytosis is plasma membrane 
repair and remodeling. Injuries to the plasma membrane results in calcium 
entering cells through the injury lesions. Sudden and rapid increases in calcium 
provokes an almost immediate response by the lysosomes. The resultant secretory 
lysosomes carrying acid sphingomyelinase (ASM) fuse with the plasma membrane 
at the damaged sites, creating “patches” to reseal the lesions. This response by 
the cell happens within seconds and is necessary to prevent bacterial and 
protozoan pathogen invasion (Norma W. Andrews 2002; N. W. Andrews 2000; 
Reddy, Caler, and Andrews 2001; Huynh et al. 2004; Gerasimenko, Gerasimenko, 
and Petersen 2001).  
 
Defects in lysosomal secretion through mutations in any of the various 
aforementioned players can result in impaired immune responses (Carmine 
Settembre, Carmine, Alessandro, et al. 2013), osteopetrosis (Lacombe et al. 
2013), neurodegenerative diseases (Klein et al. 2005), and lipid storage disorders 
(Samie and Xu 2014). 
 
Signaling 
Adding to its repertoire of functions, the lysosome is also a regulator of cellular 
homeostasis. As the major site for cellular components and macromolecules, the 
lysosome is uniquely positioned as the cell’s nutrient sensing center. Contents of 
the lysosome captures the cell’s metabolic state at any given moment as the 
degradative products from the trafficked cargo are delivered to the organelle. 
When the a class of lysosomal substrates, i.e., proteins, is low within the cell, 
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then the degradative products, i.e., amino acids, are also low within the lysosomal 
lumen. Therefore, the lysosome is central to maintaining cellular homeostasis, 
particularly its metabolism and growth. A major protein complex on the 
lysosome is the lysosome nutrient sensing machinery (LYNUS), consisting 
primarily of mechanistic target of rapamycin complex 1 (mTORC1) (See Figure 
1.3) (Carmine Settembre, Carmine, Alessandro, et al. 2013; Nnah, Khoosheh, and 
Radek 2015). As a master controller of cell growth and catabolism, mTORC1 is 
activated by anabolic factors such as growth factors, insulin, amino acids, 
oxygen, and glucose (Laplante and Sabatini 2012). Conversely, mTORC1 is 
inhibited by catabolic factors such as starvation, leading to the quelling of growth 
to save energy (Carmine Settembre, Carmine, Alessandro, et al. 2013; Nnah, 
Khoosheh, and Radek 2015; Efeyan, Zoncu, and Sabatini 2012; Mony, Benjamin, 










LYNUS permits the lysosome to play a key role in the metabolic homeostasis of 
cells. As cargo is shuttled to the lysosome, the lumen provides a measure of 
insight to the metabolic status of the cell. Increases in substrate levels would 
reflect the availability of such substrates for the cell. Indeed, mTORC1 and the 
lysosome are connected by at least theorized one amino acid sensor(Zoncu et al. 
2011) that involves V-ATPase, and likely by glucose and lipid sensors as well. 
For mTORC1 to bind and come to the surface of the lysosome,  amino acids 
must accumulate within its lumen. An accumulation of amino acids beyond a 
critical concentration activates mTORC1, thereby promoting the utilization of 
amino acids and anabolic pathways including mRNA translation, de novo lipid 
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synthesis, de novo synthesis and other pathways necessary for anabolic cell 
growth and proliferation.(Laplante and Sabatini 2012; Yu et al. 2010) As the 
degradative products from the lysosome are utilized by the cell, amino acid levels 
drop within the lysosome, eventually leading to the inactivation of mTORC1 . 
Discussion of mTORC1 signaling is further explored in the “Autophagy” section 
of this chapter. 
 
The amino acid sensor has been proposed, and its existence only indirectly shown 
up until recently, when Rebsamen et al. found that the amino acid transporter, 
member 9 of the solute carrier family 38 (SLC38A9) interacted with various 
proteins involved in mTORC1 activation. Overexpression of SLC38A9 enabled 
mTORC1 activity to persist even under extreme starvation. SLC38A9 likely 
interacts with v-ATPase to enhance this phenomenon, although the exact 
mechanisms are still unclear. The endolysosomal ATP-sensitive Na+-permeable 
channel, lysoNaATP, formed by two-pore channels (TPC1 and TPC2), may be an 
additional player connecting the lysosome with mTORC1. When mTORC1 is 
liberated from the lysosomal membrane during starvation, lysoNaATP opens, 
regulating both amino acid homeostasis and lysosomal pH stability (Rebsamen et 
al. 2015; Zoncu et al. 2011). The existence of this channel allows lysosomes to 
respond to cytosolic ATP levels and couple them to nutrient availability (Zoncu, 
Efeyan, and Sabatini 2011).  
 
Complexity of the nutrient sensing machinery and its dependence on the 
lysosome demonstrate the expansive nature the lysosome. Our understanding of 
lysosome structure and function are evolving rapidly, providing previously 
unrecognized roles of lysosomes in cellular homeostasis. This dissertation hopes to 





Lysosomes require the full function of over a hundred proteins, not only for the 
structural and degradative maintenance of the organelle, but also for the 
regulation of its signaling operations. The large number of proteins therefore 
require coordinated and organized regulation. Microarray data have recently 
identified a “lysosomal gene network” that coordinates the production of proteins 
required for lysosome assembly. This gene network along with the regulators of 
lysosome have provided insights to how the cell manages to govern one of the 
most intricate and complex organelles it houses. 
 
CLEAR Network 
The identification of the lysosomal gene network, also known as the coordinated 
lysosomal expression and regulation (CLEAR) network, demonstrates the global 
control and coordination of the transcription of lysosomal associated genes. A 
systems biology approach to microarray data of known lysosomal genes 
uncovered a 10-base, palindromic sequence, within the promoters of many 
lysosomal genes. This site, an E-box, allows for the binding of transcription 
factors belonging to the basic helix-loop-helix (bHLH) (Palmieri et al. 2011). 
Discovery of the CLEAR network is a major tool that allows researchers to 




Transcription factor EB, or TFEB, was only recently recognized as a master 
regulator of lysosomal function and biogenesis (Medina et al. 2011). As a global 
regulator of lysosomes, TFEB exerts transcriptional control over lysosomal and 
autophagosome biogenesis, lysosome degradation and exocytosis, substrate 
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targeting, and fatty acid oxidation (C. Settembre et al. 2011; Carmine Settembre, 
Carmine, De Cegli, et al. 2013; Carmine Settembre, Carmine, and Andrea 2011; 
C. Settembre et al., n.d.; Carmine Settembre et al. 2012; Roczniak-Ferguson et 
al. 2012).  
 
Under normal fed conditions, mTORC1 sits on the lysosomal membrane and 
phosphorylates TFEB at conserved serine residues. This action by mTORC1 
sequesters TFEB to the lysosomal surface, preventing its translocation to the 
nucleus (Sardiello et al. 2009; C. Settembre et al. 2011). While there are at least 
ten phosphorylation sites identified on TFEB, only two, Ser211 and Ser142, have 
been shown to be necessary for the sequestration of TFEB in murine models 
(Carmine Settembre et al. 2012; Jose A. Martina et al. 2012; Roczniak-Ferguson 
et al. 2012). Conversely, under fasting conditions, the nutrient status signalled by 
the lysosome inactivates mTORC1 via Ragulator, thereby inhibiting mTORC1’s 
actions on TFEB. Non-phosphorylated TFEB, now free of mTORC1’s 
localization control, moves to the nucleus binding promoters of genes that 
modulate various aspects of lysosome regulation, autophagy, and lipid catabolism 
(See Figure 1.4) (Maxfield, Willard, and Lu 2016). 
 
TFEB is a member of the microphthalmia-associated transcription factor (MITF) 
group of transcription factors, a subfamily of bHLH transcription factor family 
(Massari and Murre 2000). TFEB binds to the CLEAR sites of lysosomal 
associated genes, located in the promoter region (Carmine Settembre and Medina 
2015). Interestingly, based on data from C. elegans studies, the TFEB 
orthologous gene, hlh30, acts in complement to MAX-like protein X 3 (MLX-3) . 
A transcriptional repressor, MLX-3 sits on the promoter region of lysosomal 
associated genes, in particular, the C. elegans lysosomal lipases, lipl1 and lipl3. 
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Fasting degrades MLX-3 protein levels, allowing for HLH30 to bind to the 
CLEAR sequence and transcribe genes in the CLEAR network (Maxfield, 
Willard, and Lu 2016; Carmine Settembre, Carmine, De Cegli, et al. 2013; 











In addition to TFEB, MITF/TFE3 are two members of the bHLH transcription 
factor family that have been implicated in the regulation of lysosomal biogenesis 
and function (Massari and Murre 2000; Meadows et al. 2007; Rehli et al. 1999; 
Mansky et al. 2002; José A. Martina et al. 2014; Steingrímsson et al. 2002). Their 
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relationship to mTORC1 and anabolism is evidenced by their association with 
melanomas (Feige et al., n.d.; Arnheiter and Heinz 2010), renal carcinomas 
(LaGrange, Lele, and Strup 2007; “Renal Cell Carcinoma Associated with Xp11.2 
Translocation and TFE3 Gene Fusions” 2012; Fall et al. 2011), and alveolar soft 
part sarcoma (Hodge et al. 2013). These two bHLH transcription factors also 
share extensive sequence homology with TFEB, further evidence for their roles in 
lysosomal regulation. In fact, both MITF and TFE3 interact with TFEB via 
dimerization and participate in subcellular translocation to activate downstream 
lysosomal associated genes (Jose A. Martina and Puertollano 2013; José A. 
Martina et al. 2014; Steingrímsson et al. 2002). This close interaction, however, 
implies that analyzing the separate and independent functions of each 
transcription factor is difficult (Jose A. Martina and Puertollano 2013; José A. 
Martina et al. 2014).  
 
While mTORC1 phosphorylates TFEB, other proteins involved in cellular 
housekeeping seem to regulate the actions of MITF. Both mitogen-activated 
protein kinase (MAPK) and wingless-related integration site (WNT) proteins 
phosphorylate and inhibit MITF. Although the same conserved sites have been 
found on the sister proteins, TFEB and TFE3, it is unclear whether or not they 
also interact with MAPK and WNT (Ploper and De Robertis 2015).  
 
FOXOs 
The forkhead box O (FOXO) transcription factor family has also been implicated 
in the regulation of lysosome function through its effects on autophagy via 
mTORC1 inactivation (Demontis and Perrimon 2010; Calnan and Brunet 2008; 
Zhao et al. 2007; C.-C. Chen et al. 2010). A catabolic protein that serves as a foil 
for insulin action, FOXOs are active during nutrient deprived states, similar to 
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TFEB/MITF/TFE3. Binding of the insulin receptor by circulating insulin 
activates the phosphoinositide 3-kinase - protein kinase B (PI3K-AKT) pathway. 
All proteins in the FOXO family contain multiple AKT phosphorylation sites; 
phosphorylation of these sites through the induction of 14-3-3 binding (Obsil et 
al. 2003; Silhan et al. 2009) prevents DNA binding, thereby inhibiting the 
transcriptional ability of FOXOs. Conversely, inhibition of downstream insulin 
signaling cascades (PI3K/AKT and MAPK/ERK) activates FOXOs (Roy, 
Srivastava, and Shankar 2010). Hence, anabolic signals directly prevent the 
actions of FOXOs. 
 
ZKSCAN3 
Similar to MITF and TFE3, zinc-finger protein with KRAB and SCAN domains 
3 (ZKSCAN3) initially came to the attention of researchers as a result of its role 
in cancer pathogenesis, specifically colorectal cancer (Lin Yang et al. 2008). Later 
studies demonstrated a role for ZKSCAN3 in multiple myeloma (L. Yang et al. 
2011), plasma cell leukemia (J. B. Egan et al. 2012), and prostate cancer (X. 
Zhang et al. 2012). Finally, five years after its initial incrimination as an 
oncogene, ZKSCAN3 was found to be a master repressor of autophagy and 
lysosome function, antithetical to TFEB (Chauhan et al. 2013). Among the genes 
affected by ZKSCAN3 include Lc3 and Wipi12 (WD repeat domain, 
phosphoinositide-interacting 2). Loss-of-function experiments show that 
ZKSCAN3 knockdown by itself can increase autophagy and lysosomal biogenesis; 
gain-of-function likewise demonstrated the opposite effect. Therefore, ZKSCAN3 
and TFEB serve complementary roles in the regulation of cellular anabolism and 







MTOR is an important regulator in many pathways, but particularly those 
involved in metabolism and cell growth. Insulin, the central peptide hormone in 
regulating carbohydrate and lipid metabolism in the body, can activate mTOR 
via both the PI3K/AKT and MAPK/ERK pathways. Insulin binds to its 
receptor tyrosine kinase, insulin receptor (IR), which phosphorylates insulin 
receptor substrate 1 (IRS-1). Phosphorylation of IRS-1 eventually leads to the 
activation of AKT. Under normal circumstances, the tuberous sclerosis proteins 1 
and 2 (TSC1-TSC2) form a complex that inhibits the GTPase activity of the G-
protein, ras homolog enriched in brain (RHEB), by hydrolyzing RHEB-GTP into 
its inactive RHEB-GDP bound off state. However, AKT phosphorylates TSC1-
TSC2, preventing the complex from exerting its inhibitory functions on RHEB. 
Consequently, RHEB stays in its GTP-bound on state and activates mTOR, 
resulting in the activation of a number of cellular pathways, including autophagy 
(Zoncu, Efeyan, and Sabatini 2011; Laplante and Sabatini 2012). 
 
Autophagy is necessary for cell survival during nutrient deprivation. As a result, 
not surprisingly, mTOR regulate autophagy. In autophagy, cellular components 
are broken down by first sequestering them into vesicles known as 
autophagosomes. These double lipid bilayer membrane vesicles are likely derived 
from the endoplasmic reticulum, Golgi apparatus, mitochondria, and plasma 
membrane (Singh and Cuervo 2011; Ana Maria Cuervo 2010). These 
autophagosomes then fuse with lysosomes, forming autophagolysosomes. This 
newly formed vesicle will contain the same enzymes found in the lysosome that 
can degrade the proteins and release its products into the cytoplasm for reuse 




One of the key regulators of autophagy, unc-51-like kinase 1, ULK1, regulates 
membrane nucleation, allowing the cellular components to become sequestered 
into autophagosome. Under nutrient depletion, 5’ adeonsine monophosphate-
activated protein kinase (AMPK) phosphorylates ULK1 on at least four sites, 
three of which have been identified as serine 555, threonine 574, and serine 637 
(D. F. Egan et al. 2011). Phosphorylation of these sites activate ULK1 activity 
by an unknown mechanism, allowing it to form a complex with its subunits, 
autophagy-related protein 13 (ATG13) and focal adhesion kinase family 
interacting protein of 200 kD (FIP200). Moreover, ULK1 governs autophagy-
related protein 101 (ATG101) and Beclin1/class III phosphatidylinositide 3-
kinase (PI3K) VPS34, necessary for the generation of the autophagosome 
membrane. mTOR suppresses ULK1 activity via phosphorylation of the protein 
at serine 757 (Kim et al. 2011). Without ULK1 function, autophagy is inhibited. 
Unlike other degradative processes such as apoptosis, autophagy is primarily a 
protective system that breaks down both damaged cytoplasmic products as well 
as undedicated nutrient stores to meet the energy demands of the cell during 
resource deprivation (Madeo, Tavernarakis, and Kroemer 2010).  
 
Other key autophagic proteins include SNAREs, vacuolar protein sorting-
associated protein (VPSs), and RABs. These proteins’ peak functions occur 
during the biogenesis of autophagosomes and are associated with mTORC1 
activity as well (Morelli et al. 2014; Moreau, Renna, and Rubinsztein 2013; Ao, 
Zou, and Wu 2014; Bento et al. 2013; Popovic et al. 2012). Many of these genes 
involved in autophagosome biogenesis are additionally regulated by TFEB and 




As a result of its cytoprotective functions, autophagy has been well implicated in 
both aberrant metabolism and accelerated aging (Carmine Settembre, Carmine, 
Alessandro, et al. 2013; Rubinsztein, Guillermo, and Guido 2011). Insulin 
resistance in humans, for example, correlates with a decreased efficacy in the 
autophagic machinery (de Kreutzenberg et al. 2010). Hepatic lipid metabolism is 
in part mediated by autophagy, where it breaks down neutral lipids via lysosomal 
acid lipase (LIPA) (Singh, Kaushik, et al. 2009). Obesity disrupts this process, 
ultimately promoting hepatic insulin resistance (Singh, Kaushik, et al. 2009). In 
the pancreas, the 𝛽-cells require intact autophagy for their expansion during high 
fat diet and insulin resistant states (Quan, Lim, and Lee 2012; Linnemann, Baan, 
and Davis 2014; Ebato et al. 2008).  
 
 
Lipid catabolism and Lipophagy 
 
Early studies of autophagy and lysosomes focused on degradation of protein and 
complex carbohydrates. However, in the last decade, researchers have identified 
critical roles for lysosomes in lipid catabolism (Singh, Kaushik, et al. 2009; 
Carmine Settembre, Carmine, De Cegli, et al. 2013). 
 
The significance of lysosomes in lipid metabolism is particularly obvious in aged 
and obese mice (Cota and Daniela 2009). Increases in age and adiposity 
hyperactivate mTORC1, making it less sensitive to nutrient signals provided by 
the lysosome (S.-B. Yang et al. 2012). Lipidomic studies show that these mice 
accumulate lipids in their lysosome (Rodriguez-Navarro et al. 2012). 
Furthermore, their lysosomes act as if partially disabled, with altered hydrolysis 
of components, cholesterol accumulation, and inability to partake in fusion as 
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well as fission. These abnormalities further exacerbate altered mTORC1 actions 
and its subsequent inappropriate downstream signaling (Rodriguez-Navarro et al. 
2012; Carmine Settembre and Ballabio 2014). 
 
Lipophagy 
Briefly, lipophagy is a form of autophagy that allows the cell to degrade lipid 
droplets (LDs). As a selective form of autophagy, lipophagy describes a vesicular 
alternative to cytosolic lipolysis by hormone sensitive lipase (HSL) and adipose 
triglyceride lipase (ATGL). The lipid droplet of the adipocyte, contrary to earlier 
beliefs, is a dynamic organelle covered by various structural and regulatory 
proteins that allow it to not only respond to cellular environmental changes, but 
also interact with other organelles (Greenberg et al. 2011; Fujimoto and Parton 
2011; Murphy et al. 2009). However, because the lipid droplet contains a protein 
coat and not a lipid bilayer, it cannot directly fuse with the lysosome for its 
contents to be hydrolyzed by lysosomal acid lipase (LIPA). Therefore, lipid 
droplet sequestration can only be performed by the autophagosome, which 
contains the necessary machinery to take in such cellular components. Key 
players in autophagy, in particular autophagy proteins 5 and 7 (ATG5 and 
ATG7), localize to fractions of lipid droplets, aiding in the formation of a limiting 
membrane at the lipid droplet. With the help of autophagy protein 12 (ATG12) 
and LC3 conjugation to phosphatidylethanolamine (PE), phospholipids begin to 
create the limiting membrane layer from the surface of the lipid droplet. Once the 
autophagosome carrying the lipid droplet fraction is fully mature, it can then fuse 
with a lysosome to deliver the lipid based contents (Singh, Rajat, and Cuervo 
2012).  
 
Previously, lipid breakdown in the cell was thought to occur exclusively in the 
cytosol by HSL, ATGL and monoacylglycerol lipase (MGL). However, studies in 
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autophagy debunked this limited view. Cells with dysfunctional autophagy 
toxically accumulate LDs in the cytoplasm. Patients suffering from hepatic 
steatosis exhibit not only excess LDs within hepatocytes, but also the presence of 
lipid filled lysosomes. Further, LIPA deficiency, a spectrum of disease from severe 
(complete lack of activity - Wolman disease) to moderate (partial lack of LIPA 
activity - Cholesteryl ester storage disease, CESD) (Aslanidis et al. 1996). 
Wolman disease patients often die before reaching one year of age from impaired 
intestinal function, liver failure, and immune defects. In contrast, CESD patients 
suffer from varying degrees of hyperlipidemia, premature cardiovascular disease, 
and hepatic steatosis that can progress to liver failure (B. Zhang, Bingnan, and 
Porto 2013; Barness 1996, 2563–2587). The presence of neutral lipases in these 
cases fail to defend the cell and organism; lysosomal-dependent lipolysis, 
including lipophagy, therefore is required for lipid homeostasis. 
 
Further connecting lysosomes to lipid degradation, the master lysosomal 
regulator TFEB, is a transcription factor for a number of lipid metabolism genes. 
These genes code from proteins that include: cluster of differentiation 36 (CD36), 
fatty acid binding protein (FABP) (for FA import through the plasma 
membrane), carnitine palmitoyltransferase 1 (CPT1), carnitine acetyltransferase 
(CRAT), acyl-CoA dehydrogenases (ACADL and ACADs), (for mitochondrial b-
oxidation of FAs), cytochrome p450, family a, subfamily 4 (CYP4a), LIPA, and 
more importantly, PGC1𝛼 and PPARs (master regulators of lipid catabolism) 
(Carmine Settembre, Carmine, Alessandro, et al. 2013). Overexpression of TFEB 
in the liver alleviated symptoms of metabolic syndrome (Carmine Settembre, 
Carmine, Alessandro, et al. 2013). Similar gain-of-function mutations in TFEB in 
macrophages delayed atherogenesis (Emanuel et al. 2014). Therefore, in addition 
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to controlling lipophagy, TFEB also ties other themes in lipid degradation to the 
lysosome.  
 
Lysosomal contribution to lipid catabolism is at its peak during nutrient deprived 
states, at least in the liver. Its contribution to meeting the energy of other cell 
types, particularly adipocytes, remain uncertain and controversial. For example, 
lysosomes in adipose tissue were originally assumed to not be of any unique or 
specialized importance. Yet, adipose tissue specific knockout of ATG7 results in 
reduced adipocyte lipid droplet size, tissue mass, and impaired adipogenesis 
(Singh, Xiang, et al. 2009). Moreover, these mice also exhibit brown adipose 
tissue like features in their white adipose tissue. However, due to inherent 
limitations in the genetic model, it is unclear if these features are results of 
developmental problems; a direct role for lipophagy in adipocyte lipid catabolism 
is not clear. In fact, data from our lab demonstrate that preadipocytes isolated 
from LIPA deficient and wildtype littermates differentiate similarly in vitro, 




A fever is a classic response to inflammation and many infections. Research on 
the study of the febrile response has revealed many complex heat sensitive 
mechanisms that assist the immune system during defense. Nonetheless, despite 
our knowledge regarding these immune processes, the source of heat during a 
fever is still an incompletely solved mystery. 
 
The induction of fever from infection is currently thought to be dependent on the 
hypothalamic response to interleukin 6 (IL-6), which function downstream of the 
other major pyrogenic cytokine, IL-1 (See Figure 1.5) (Dinarello et al. 1991; 
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Kozak et al. 1998; Netea, Kullberg, and Van der Meer 2000). Stimulation of the 
medial preoptic nucleus of the hypothalamus by IL-6 results in additional 
prostaglandin E2 (PGE2) (Matsumura et al. 1998; Yamagata et al. 2001; 
Engström et al. 2012). Following stimulation of the PGE receptor 3 (EP3) 
expressing neurons by PGE2, the sympathetic nervous system triggers the release 
of norepinephrine, activating two responses that work together to increase body 
temperature by (1) reducing heat exchange and (2) increasing heat generation 
(Engblom et al. 2003; Lazarus et al. 2007). The reduction in heat exchange in 
mammals involves decreasing circulation to the skin and reducing evaporation 
based heat exchange. There is also strong evidence for increased heat production 
through both shivering and nonshivering thermogenic mechanisms (Evans, 
Repasky, and Fisher 2015) (Figure 1.5). 
 
While many models of febrile response include activation of BAT, it is unclear 
what contribution BAT has on raising body temperature, especially in adults. A 
study from the Saito Lab provided evidence that in the absence of UCP1, mice 
are still able to mount a febrile response, putting into question the necessity of 
BAT function in febrile response (Okamatsu-Ogura et al. 2007). Furthermore, 
given the low BAT mass in humans, it seems likely that UCP1 independent 












In studies of lysosomal acid lipase, we discovered that lysosomes are critical for 
thermogenesis and propose that they contribute to the regulation of heat 
generation in three ways: 1) As regulatory organelles that modulate transcription 
necessary for UCP1-dependent thermogenesis; 2) By providing substrates for 
uncoupled oxidation; 3) As thermogenic organelles that generate heat through 






Model #1: Lysosomes indirectly regulate lipid catabolism and NST genes through 









As a recently discovered major signaling center of the cell, the lysosome is home 
to a number of critical metabolic proteins. TFEB, in addition to other members 
of the CLEAR domain binding transcription factor family, is intimately 
associated with lysosomal activity via mTOR. TFEB is upstream of a number of 
pathways, including lipid catabolism, via the actions of PGC1𝛼. As a crucial 
 
 45 
transcription factor for UCP1, PGC1𝛼 can subsequently regulate NST. Therefore, 
we hypothesize that lysosomes contribute to NST activation via TFEB and other 
members of the CLEAR transcription factor family. 
 
Description of signaling model:  
Cold exposure demands profound levels of energy from the brown adipocyte as 
the efficiency of ATP production drops to compensate for the production of heat. 
As a result, food intake and catabolism must increase to support the sudden rise 
in energy demand. This changed state alerts the LYNUS machinery to activate 
TFEB to increase transcription of catabolic genes, including PGC1𝛼. 


















Model #2: Lysosomes contribute to heat generation directly as thermogenic 
organelles. 
 
Figure 1.7: Lysosomes are thermogenic organelles. 
 
Rationale:  
Thermodynamics deem that perfectly efficient reactions in nature do not exist; 
that is, entropy is always positive. While the laws of thermodynamics and 
entropy are generally constrained in the to the fields of physics and chemistry, 
they form the critical basis for thermogenesis studies. Nonshivering 
thermogenesis, as we currently understand it, is defined by the uncoupling of 
biochemical reactions from the creation of useful chemical energy such as ATP, 
resulting in heat dissipation. While there are two well known systems that 
participate in this phenomenon: UCP1 activation in brown adipocyte 
mitochondria as well as SERCA actions in stimulated muscle fibers, it is not 




Further, many catabolic reactions like those that occur in the lysosome are 
exothermic, releasing small amounts of heat to abide by the second law of 
thermodynamics. By regulating delivery and degradation of high-energy 
macromolecules, cells can generate heat in a UCP1 independent fashion. 
Consequently, we hypothesize that any cell with lysosomes can generate heat. 
The question is not whether lysosomes are at all thermogenic, but rather are 
physiologically relevant thermogenic organelles.  
 
Description of heat generation model:  
Cold challenge induces substantial catabolism, increasing exothermic heat release 

















Generation of fatty acids for uncoupled oxidation is necessary for BAT 
thermogenesis. We hypothesize that lysosomes, through the action of lysosomal 
acid lipase (LIPA), hydrolyze triglycerides into free fatty acids and glycerol. 
Lysosomal derived free fatty acids serve as critical substrates for the 





Description of substrate model:  
During cold challenge, lysosomes shuttle large amounts of free fatty acids to the 
mitochondria for NST use. Lipids may enter through classical means: lipophagy, 
reësterified triglycerides from the circulation, lipoproteins, CD3 uptake of lipids. 
These sources of lipids, once delivered to the lysosome, can then hydrolyzed by 
the residing lysosomal acid lipase. Subsequently, the free fatty acid products and 
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Lysosomes are critically important for the regulation of cellular homeostasis 
(Settembre et al. 2013). Body temperature management likewise is equally 
necessary for the maintenance of whole body physiology. We hypothesized that 
lysosomes contribute to regulated thermogenesis in three ways: as signaling nodes 
that monitor substrate availability, as substrate providers for uncoupled 
oxidation and as heat generating organelles. If any aspect of our hypothesis is 
correct, then we predict that activation of nonshivering thermogenesis will 
activate lysosome function in thermogenic organs.  
 
Organisms activate thermogenesis in response to drops in ambient temperature 
and as a physiological part of inflammatory responses. Homeotherms activate 
thermogenesis when the ambient temperature drops below the point at which 
basal metabolism and circulatory responses are insufficient to maintain body 
temperature - defined as the “thermoneutral temperature.” There has been great 
interest in cold induced thermogenesis, and many studies largely center around 
UCP1-dependent uncoupled oxidation. In comparison, there have been relatively 
few studies of thermogenesis in febrile responses or in local heat generation during 
injury and inflammation. There have been even fewer studies of UCP1-
independent thermogenesis, yet the existence of non-canonical thermogenesis is 
compelling. UCP1-deficient mice are able to mount a thermogenic response and 
survive in cold environments when previously acclimated (Nedergaard et al. 2001; 
 
 80 
Golozoubova 2001). Similarly, birds lack functional UCP1 homologue, yet they 
live in some of the coldest environments on Earth (Emre et al. 2007). 
Additionally, animals with defective brown adipose tissue (BAT) thermogenesis, 
including ones with defective leptin signaling, are able to mount febrile responses 
that are indistinguishable from mice with intact BAT (Okamatsu-Ogura et al. 
2007).  
 
Regulation of body temperature, of course, is not limited to the traditional 
narrow scope and view of nonshivering thermogenesis. The raising of body 
temperature during a febrile response represents another facet to body 
temperature control. While the current febrile response model involves the actors 
PGE, IL6, and UCP1 (Evans, Repasky, and Fisher 2015), we hypothesized that 
lysosomes may be an additional influencer in the model. In other words, 
lysosomes may be important not only for the defense of body temperature, but 
also for its increase. Consequently, in this chapter, we also explore whether 
induction of a febrile response through infection mimicry could result in a 
likewise increase in lysosomal associated genes. 
 
Finally, given the importance of whole body temperature homeostasis in nearly 
all animals, lysosomes may be a conserved undiscovered temperature regulating 
mechanism even in poikilotherms. While homeotherms have well established 
molecular defenses against a cold challenge, most adaptations by poikilotherms 
seem to be behavioral (Heath 1970). We propose, given the lack of Ucp1 
expression in poikilotherms, that lysosomal activity may be a conserved 
evolutionary response to cold challenge. 
 
Naturally, a mere association between the two phenomena does not describe a 
physiologically relevant and causative relationship. To establish such a rapport 
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between thermogenesis and lysosomes, we will explore whether disruption of 
lysosomes alters the response by thermogenic tissues. Both pharmacological and 
genetic approaches can be used to create a lysosomal dysfunctional phenotype. If 
these lesions are capable of altering the thermogenic actions of brown and beige 
adipocytes after a cold challenge, then lysosomes have either direct or indirect 
effects on cold sensitivity. Febrile responses in lysosomal disruption models will 
further corroborate the causal relationship between lysosomes and body 
temperature regulation. 
 
Proposed Hypothesis and Model:  
The lysosome has a correlative relationship between its activity and body 




Methods and Materials 
 
 
Animals and Animal Care.  
FVB/NJ mice were obtained from the Jackson Laboratory at 6-7 weeks of age, or 
from the laboratory stock of lysosomal acid lipase (LIPA) mice, originally 
generously provided by Hong Du, PhD of Indiana University. LIPA knockout 
mice are missing exon 5 of the LIPA gene, resulting in a dysfunctional LIPA 
transcript. Experiments were performed on littermates. Mice were housed in 
ventilated Plexiglas cages within specific pathogen-free barrier facility maintained 
in a 12-hour light/12-hour dark cycle. Regular water and chow diet were 
provided ad libitum. LIPA deficient mice were genotyped using polymerase chain 
reaction screening of tail DNA. All procedures were approved by the Columbia 
University International Animal Care and Use Committee. 
 
Quantitative Real-time Polymerase Chain Reaction.  
Tissue samples were immediately frozen by liquid nitrogen from euthanized mice 
at the termination of experiments. RNA was extracted from frozen tissue samples 
using an acid-phenol reagent according to manufacturer’s instructions (RNA-solv 
reagent, Omega Bio-tek). RNA was further purified by silica-membrane method 
from the manufacturer (E.Z.N.A. Total RNA Kit II, Omega Bio-tek) and then 
used as template for cDNA synthesis (qScript cDNA SuperMix, Quanta 
Biosciences). Quantitative real time PCR (qRT), was performed using white 384 
well plates in the Roche LightCycler 480 machine. Analysis was done by 
normalizing expression to Rps3 and expressed in relative units using the DDCT-2 
method, taking account of each primer efficiency calculated per in-run standard 





Tissue samples were homogenized by sterile stainless steel beads with QIAGEN’s 
TissueLyser LT in tissue lysis buffer (Tissue extraction reagent I, Thermo Fisher) 
treated with protease and phosphatase inhibitors (Protease inhibitor cocktail I, 
phosphatase inhibitor cocktail II and III, SIgma Aldrich). Protein concentrations 
were determined by standard BCA assay (Bio-Rad). Crude protein extracts were 
centrifuged to separate the lipid fraction from the aqueous layer three times to 
purify protein. Purified protein extracts were gel electrophoresed using 10% 
SDS/PAGE gels, transferred to PVDF .2 um membranes (Millipore info), and 
immunostained according to standard methods. Antibodies used: UCP1 (info), 
LAMP1 (info), LAMP2 (info), PGC1 (info), PPARy (info), phospho-p38MAPK 
(info), p38MAPK (info), b-actin (info), a-tubulin (info). Blots were visualized 
using LI-COR fluorescent secondary antibodies and a Li-COR imager. 
 
Protein densitometry.  
Protein densitometry was calculated using ImageJ. ALl protein are normalized to 
either beta-actin or alpha-tubulin for whole cell or cytoplasmic fractions. TATA-
binding protein (TBP) was used as the control protein for nuclear fractions. 
 
Lysosomal acid lipase activity assay.  
LIPA activity was determined using a 4-methylumbelliferyl oleate assay with 4-
methyumbelliferone serving as the standard curve. 4-MUO was dissolved in 
hexane at 100 mg/ml and diluted 1 to 250 in 4% Triton X-100. Tissue extracts 
were prepared in the same way as western blot samples (see Immunoblots). 25 ul 
of diluted tissue extracts, 50 ul of diluted 4-MUO substrate, and 125 ul of assay 
buffer (0.2 M NaOAc and 0.01% Tween 80, pH 5) were incubated at 37flC for 30 
minutes. To stop the reaction, 100 ul of 0.75 M Tris, pH 8.0 was added to each 
sample. Fluorescence was detected using at excitation 360 nm and emission 460 
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nm. Relative fluorescence units from each sample were then compared to that of 
the standard curve and normalized to wildtype controls. 
 
Histology, Immunohistochemistry, and Immunofluorescence.  
Histology was performed by Columbia University Medical Center Russ Berrie’s 
Pathology Core. Sections were sliced at 5um and paraffin-embedded. For IHC 
staining, adipose tissues were fixed with Z-FIX for 48 hours and embedded in 
paraffin. Tissue sections (5mm thick) were deparaffinized, rehydrated, and 
followed by antigen retrieval step before being stained with ABC/DAB 
(Vectastain) kit followed by counterstain. Antibodies used for IHCs: Ucp1 (info). 
For IF staining, adipose tissues were fixed in 4% PFA for 24 hours, followed by 
10% sucrose and embedded in OCT before freezing. Tissue sections (5mm thick) 
followed the standard IF protocol described by AbCam. IF slides were mounted 
using Invitrogen’s ProLong Gold antifade reagent with DAPI . Antibodies used: 
LAMP1 (eBioscience), LAMP2 (Abcam), PLIN1 (Abcam), and M6PR (Abcam). 
 
Brown adipose tissue isolation. 
Brown adipocytes were isolated from extracted whole interscapular brown 
adipose tissue. Tissue were minced such that individual pieces were ¡1 mm or less 
in diameter in 350 ul of cell medium, resulting in a tissue slurry. Following 
mincing, the tissue slurry was placed in cell medium with liberase (Roche) and 
incubated at 37C with shaking for 30-50 minutes, depending on the efficiency of 
the liberase stock. The resulting solution was passed through a 100 micron cell 
strainer (Gibson) and centrifuged at 500g for 10 minutes. The supernatant was 
removed and the cells were reconstituted in 5 mLs of cell medium before being 
centrifuged again at 500 g for 10 minutes. Cells were then reconstituted in cell 





Splenocytes were isolated from whole spleens extracted from sacrificed mice. 
Following extraction, splenocytes were placed in a plate containing a 70 micron 
cell strainer immersed in cell medium. A 10 mL syringe plunger was used to press 
the whole spleen within the cell strainer against the plate wall. After filtering the 
ground tissue through the cell strainer, cells were centrifuged at 500g for 5 
minutes. Following centrifugation, cells incubated in a lysis buffer for five 
minutes at room temperature (Invitrogen) to lyse the erythrocytes. The 
suspension was then pelleted again via centrifugation at 500g for an additional 5 
minutes before resuspending again in two mLs of cell medium. Cells were counted 
for concentration prior to ITC measurements. 
 
Chloroquine injections.  
Chloroquine (Sigma-Aldrich), a lysosome inhibitor, was injected either 
intraperitoneally or directly into the BAT tissue at 3.5 mg/kg.  
 
CL 316,243 injections. 
CL-316,243 (Sigma-Aldrich), a beta3-adrenergic receptor agonist, was injected 
intraperitoneally at 1 mg/kg. Mice were sacrificed 2 hours post injection. 
 
Liver isolation.  
Portions of the right anterior and left medial segments of the murine liver was 
removed from the whole liver for each isolation, unless otherwise specified. 
 
Skeletal muscle isolation.  
Whole soleus and extensor digitorum longus muscles were removed from each 




Lipopolysaccharide injections.  
Lipopolysaccharide (Sigma-Aldrich L5418-2ML) was injected intraperitoneally at 
10 ug/kg and monitored every two hours (unless otherwise specified) via a 
temperature probe. 
 
Polyinosinic:polycytidylic acid injections.  
Polyinosinic:polycytidylic acid (Sigma-Aldrich P9582-5MG) was injected 
intraperitoneally at 5 ug/kg and monitored every two hours (unless otherwise 
specified) via a temperature probe. 
 
Cold challenge.  
Mice were housed individually for up to 72 hours in 4-8flC. Cold challenge 
experiments for this chapter allowed ad libitum access to regular chow diet and 
water. Mice followed the same 12 hr day/12 hr night cycle of the Columbia ICM 
specific pathogen free housing. 
 
Statistics. 
Significance calculations of comparisons between two groups were determined by 
student’s t-test. Significance calculations of multiple group comparisons were 
determined first by ANOVA and then Bonferroni correction. Key for all 
significance indications: * = p-value ≤ 0.05; ** = p-value ≤ 0.01; *** = p-value ≤ 
0.001.  
 
Figures represent one experiment out of four. Data are not combined to produce 








Cold challenge induces a lysosomal biogenesis program in brown adipose tissue.  
We hypothesize that lysosomes contribute to regulated thermogenesis. To test 
this one aspect of our model, we assessed whether cold exposure activates a 
lysosomal program as our model predicts. We placed 7-8 week old male FVB/NJ 
mice in the cold (4-8°C) and littermates at room temperature (20-25°C). Mice 
were sacrificed after 8, 18, or 72 hours at 4-8C. Brown (BAT), subcutaneous 
(SUBQ) and epididymal (EPID) fat depots were collected for analysis. Using 
quantitative real-time polymerase chain reaction (qRT) we measured expression 
of lysosome and thermogenic genes and compared mRNA transcripts levels 
between room temperature and cold challenged mice. Lysosomal genes were 
upregulated in 8 and 72 hour time points, but not at 18 hour time point in the 
BAT (Fig 2.1-2.3). These genes include the lysosomal regulators, transcription 
factor EB (Tfeb), a positive transcriptional regulator of lysosomes (Sardiello et al. 
2009), zinc finger protein with KRAB and a negative regulator SCAB domains 
(Zkscan3) (Chauhan et al. 2013), lysosomal membrane associated proteins, 
Lysosomal associated membrane protein 2 (Lamp2), Chloride channel voltage 
sensitive 7 (Clcn7), and the h subunit of ATPase, H+ transporting, V1 subunit 
(Atp6v1h). We also found cold-induced upregulation in expression of genes 
encoding lysosomal hydrolases such as lysosomal acid lipase (Lipa) and 
glucosamine-6-sulfatase (Gns).  
 
To determine whether cold-induced lysosome gene expression resulted in increases 
in lysosomal proteins, we measured the LAMP1, LAMP2, and LIPA protein 
levels in BAT from mice at 4°C and 25°C. (Fig 2.4-2.9). Consistent with the gene 
expression data, each protein level was increased by cold exposure at 8 and 72 
hours, but not at 18 hours. This pattern was further corroborated by the LIPA 
 
 88 
activity levels (Fig 2.10) and the immunofluorescence of LAMP1, and perilipin 1 
(PLIN1) (Fig 2.11). Together these data demonstrate that cold induces lysosome 
biogenesis in BAT. They also suggest that there is a bimodal wave of lysosome 
biogenesis and function, one occurring early and then a second after 24hrs.  
 
Cold challenge does not induce the same lysosomal program in white adipose 
tissues. 
Some white adipose tissue depots contain thermogenic beige adipocytes and their 
precursors (Giralt and Villarroya 2013). Beige adipocytes, unlike their white 
counterparts, are rapidly activated during cold exposure. To determine whether 
cold induces lysosome biogenesis in other fat depots, we examined the lysosomal 
program in subcutaneous and perigonadal depots. Surprisingly, when we a cold 
challenge did not induce a lysosomal program (Fig 2.12-2.14) at 8 or 18 hours in 
gene expression. However, we did notice a modest increase in Lamp2 gene 
expression level and LIPA activity at 72 hours (Fig 2.14). These data were 
further corroborated by the LIPA activity assay (Fig 2.15) as well as LAMP1 
protein blots (Fig 2.16-2.21). Taken together, this suggests that unlike in BAT, 
ambient cold temperature that induces thermogenesis does not robustly induce 
lysosomes in the SUBQ but may have some effect at a more chronic challenge.  
 
Lysosomes are upregulated in non-UCP1 tissues. 
We hypothesized that if lysosomes contribute to heat generation directly, then 
cold challenge would be correlated with an upregulation of lysosomal program 
even in nonUCP1 tissues. Therefore, we cold challenged 7-8 week old FVB/NJ 
wildtype mice and isolated various nonUCP1 tissues, liver, kidney, heart, spleen, 




Given the upregulation of lysosomes in prolonged cold challenge in BAT, we 
assessed the lysosomal program in non-UCP1 tissue after 72 hours at 4-8°C to see 
whether cold challenges regulated lysosome biogenesis in other tissues. While we 
saw no induction of lysosomal transcripts in kidney (Fig 2.22) and heart (Fig 
2.23), the expression of lysosomal genes were to varying degrees induced in slow-
twitch skeletal muscle (soleus) (Fig 2.24), spleen (Fig 2.25), and in the liver (Fig 
2.26). Consistent with our observations in BAT, a cold challenge that induces 
nonshivering thermogenesis also induced protein and LIPA activity (except in the 
soleus) consistent with the induction of gene expression (Fig 2.27-2.35). Both 
methods corroborated the transcriptional activation of lysosomes in soleus, spleen 
but not in the liver. Consistent with the qRT findings, the kidney, heart, and the 
EDL saw no increases or even decreases in lysosome protein and activity. 
Together, these data demonstrate that lysosomes are activated in a tissue specific 
manner in UCP1 negative tissues after prolonged exposure to 4-8°C.  
 
Immune cell populations of the spleen are increased after cold challenge. 
We were surprised to see activation of lysosome biogenesis and activity in spleens 
of cold challenged mice. The spleen is a heterogeneous organ that histologically 
includes the red and white pulp. Red pulp consists of mesenchymal cells, 
platelets, granulocytes, and red blood cells (“Basic Histology” 2016). White pulp, 
on the other hand, contains large numbers of B and T lymphocytes, as well as 
antigen presenting cells (APCs), including macrophage/monocytes populations, 
and dendritic cells. Our data on cold induced lysosome activation in spleen 
suggest that immune cells may be directly regulated by cold. To understand how 
the cell population might change after cold challenge in the whole spleen, we 
performed qRT-PCR of various immune cell markers. Genes examined included: 
activated leukocyte cell adhesion molecule (Alcam), cluster of differentiation 2, 4, 
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8a, 19, 28, and 200r1 (Cd2, Cd4, Cd8a, Cd19, Cd28, Cd200r1), which mark T- 
and B-lymphocytes, cluster of differentiation 40, 69, (Cd40, Cd69), EGF-like 
module-containing mucin-like hormone receptor-like 1 (Emr1, or F4/80), endoglin 
(Eng), which mark monocytes, macrophages, and dendritic cells, and other 
markers: cluster of differentiation 86 (Cd86, marking activated B-cells, 
monocytes, macrophages, and dendritic cells), dipeptidyl-peptidase (Dpp4, 
marking activated T-cells, monocytes, and macrophages), tyrosine protein kinase 
1 (Tek1, marking endothelial cells) (Yakimchuk and Konstantin 2016)(Suttles, 
Jill, and Stout 2009; Cambiaggi et al. 1992; Khazen et al. 2005; Gougos et al. 
1992; Waumans et al. 2016; Matteucci and Giampietro 2009). Cold increased 
Cd45 expression - a gene expressed by all leukocytes, and increased expression of 
lymphocyte-specific genes (Fig 2.36). We found modest changes in monocyte, 
macrophage, and dendritic cell populations as well (Fig 2.36). Furthermore, these 
data are supported by flow cytometry: Lysotracker (LS) positive cells are 
increased after cold challenge and are largely F4/80+. Lysosome rich immune 
cells, as marked by Lysotracker (LS) and CD11B, were more likely to be F4/80 
positive, implicating macrophages in the lysosome phenotype (Fig 2.37 and 2.38).  
 
Finally, in the lysosomal storage disease model of LIPA deficiency, we found that 
these same immune cell changes were blunted (Fig 2.39). This observation 
suggests that the immune cell population changes in the spleen after cold 
challenge may be contributing to the lysosome phenotype we observe. 
 
Lysosomes are upregulated in cold challenged poikilotherms. 
Whereas homeotherms maintain internal body temperature within a relatively 
narrow range and typically have complex mechanism to modulate both heat 
exchange and thermogenesis, poikilotherms, seem to lack complex 
thermoregulatory systems. Therefore, their internal body temperatures typically 
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varies more widely. Nonetheless, given the importance of core body temperature 
in the function of an organism, many poikilotherms have evolved adaptations to 
drastic variations in environmental temperature (Heath 1970). While 
poikilotherms lack UCP1 and any known mechanism to uncouple respiration, 
they do contain lysosomes or vacuoles. Given that modulation and adaptation to 
variations in the ambient temperature and lysosome degradation are 
evolutionarily ancient, we hypothesized that cold challenges would activate 
lysosome program in poikilotherms.  
 
We examined the effects of cold challenge on the poikilothermic, Drosophila 
melanogaster larvae. Two temperatures were chosen: 20-25°C and 15-18°C. 20-
25°C is the optimal functional temperature for Drosophila, while at 15-18°C flies 
can survive but are impaired in the metabolic and developmental functions. 
Consistent with our hypothesis, the cold temperature coordinately induced 
expression of several lysosomal genes, including, lysosome associated membrane 
protein 1 (lamp1), lipase 1 (lip1), v-type proton ATPase subunit 13 (vha13), and 
vacoular protein sorting 16 (vps16, responsible for lysosome trafficking) (Pistillo 
et al. 1998; Tognon et al. 2016; Pulipparacharuvil et al. 2005). In addition, 
several genes involved in autophagy were also increased (in autophagy-related 
gene 8 (atg8, an autophagy gene), chloride channel b (clc-b, chloride channel 
found on Drosophila lysosomes), diabetes- and obesity-regulated gene (dor, an 
autophagy regulator)(Fig 2.40) (Alemu et al. 2012; Cabrero et al. 2014; Mauvezin 
et al. 2010). These preliminary results demonstrate that a cold-induced lysosomal 
transcriptional program is evolutionarily ancient.  
 
Febrile response is correlated with lysosomal genes and protein. 
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Our data demonstrate that lysosomal programs are activated in response to drops 
in ambient temperature, consistent with our model that they contribute to 
regulated thermogenesis. Fevers in mammals also require nonshivering 
thermogenesis. To test whether a lysosomal program is activated in response to 
induction of febrile thermogenesis we used two pathogen derived pyrogenic 
compounds: lipopolysaccharide (LPS) from gram-negative E. Coli and synthetic 
polyinosinic-polycytidylic acid (poly(I:C)), a mimetic for viral dsRNA. We 
injected either LPS, Poly(I:C), or saline into lean, young mice and monitored 
body temperatures every two hours. After injection, we sacrificed the mice and 
measured expression of lysosomal genes in BAT and spleen. LPS induced the 
expression of half the lysosomal genes we measured in BAT and about a fifth of 
the ones in the spleen (Fig 2.41 and 2.42). While LAMP1 protein was not 
induced by LPS (Fig 2.43 and 2.44), it did increase LIPA activity in BAT (Fig 
2.45), though not in spleen (Fig 2.46).    
 
Chloroquine, a lysosomal inhibitor, impairs thermogenic response. 
We have found that in response to thermogenic stimuli, lysosomal programs 
become activated in BAT as well as other tissues not previously implicated in 
regulated thermogenesis. To investigate whether BAT lysosomal function 
contributes to thermogenesis and maintenance of body temperature in response 
to a cold challenge, we treated mice with chloroquine (CQ), a lysosomal inhibitor 
that reduces the acidification of late endosomes and lysosomes. We injected 3.5 
mg/kg of CQ or PBS into the IP of eight week old wildtype FVB mice. Following 
IP injection of either CQ or phosphate-buffered saline (PBS), the mice were cold 
challenged at 4°C and temperatures were taken via a rectal probe every two 
hours. Mice that were injected with CQ dropped temperatures at 4°C while the 
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littermate controls injected with PBS maintained body temperatures (Fig 2.47) 
suggesting a functional role for lysosomes in thermogenesis. 
 
To determine whether inhibition of lysosome function with CQ would also impair 
the febrile response we injected mice with either LPS or poly(I:C). CQ or PBS 
was injected IP into LPS and poly(I:C) treated animals. Similar to what we 
observed with cold challenged animals, CQ reduced the body temperature and 
febrile response of mice in LPS (Fig 2.48) or poly(I:C) (Fig 2.49) treated animals.  
 
Disruption of LIPA function results in cold intolerance. 
In our studies of cold-induced and febrile thermogenesis we noted a consistent 
increase in the expression and activity of Lysosomal acid lipase, the only known 
acid lipase in mammals. To test whether genetic deficiency in Lipa would impair 
thermogenesis, we studied the response of Lipa-/- mice to cold challenge and 
LPS. Lipa-deficient mice are born without gross defects, but starting at 8 weeks 
of age, begin to lose white adipose tissue and expand BAT. To avoid possible 
confounding issues, we performed experiments in LIPA KO mice prior to any 
significant morphological differences in BAT or SUBQ depots between knockouts 
and wildtypes, at 6-8 weeks of age.  
 
Cold challenge of LIPA-deficient and wildtype littermates showed that LIPA 
deficiency impairs thermogenesis. Lipa-/- mice rapidly lost body temperatures 
(Fig 2.50). Tissue analysis revealed that BAT histology (Fig 2.51), lysosomes, 
mitochondria, and trafficking functions of knockout mice are indistinguishable 
from those of wildtype mice (Fig 2.52). Taken together, these data suggest that 
lysosomes are not only correlated with cold challenge, but also necessary for 





We found that thermogenic stimuli induce a lysosome program and that 
inhibiting lysosomes pharmacologically or genetically impairs cold-induced and 
febrile thermogenesis. The cold-induced lysosomal program is not limited to the 
classical thermogenic tissue, BAT but is also detectable in spleen, muscle and 
liver. The transcriptional induction of a lysosomal program in response to a cold 
challenge also appears to be evolutionarily ancient being induced in Drosophila 
larvae in addition to mice. Together these findings argue that lysosomes 







As the primary degradative organelles of cells, lysosomes play central roles in the 
many processes, including processing of antigen for presentation, killing of 
intracellular pathogens, autophagy and recycling of cellular debris, secreting of 
hydrolases, and even a process of lysosomal-dependent cell death (Settembre et 
al. 2013; Ballabio 2016; Appelqvist et al. 2013). Based on the data presented in 
this chapter, we have discovered that lysosomes also participate in regulated 
thermogenesis. We demonstrate that lysosomes are upregulated in a tissue-
specific manner by thermogenic stimuli, including a cold challenge and inducers 
of fever. Pharmacological and genetic data further implicate lysosome function as 
critical for generating heat and maintaining or increasing body temperature.  
 
In mice and humans, most research on nonshivering thermogenesis has centered 
on UCP1 uncoupling of oxidation in BAT and beige adipose tissue. However, 
several lines of evidence point to the existence of nonUCP1 dependent 
mechanisms of NST. Mice that lack UCP1 can maintain body temperature in the 
face of a cold challenge in a manner that depends on strain background and on 
the rate at which mice are transitioned to a cold environment. Birds lack a 
functional homologue of UCP1 yet are homeotherms and are capable of 
maintaining body temperature in extreme cold, providing indirect evidence for 
nonUCP1 mechanisms of thermogenesis. Additionally, there exist several plants 
that are thermogenic. The generation of heat by these organisms are thought to 
play multiple roles, including attracting insects. To our knowledge none of these 
studies have focused thermogenesis as part of these adaptive responses.  
 
We posit that lysosomes are part of a thermogenic response of organisms that 
does not dependent on the expression of UCP1. Indeed, in mice we found that 
lysosomes were upregulated in some, but not all, of the tissues examined. These 
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tissues included muscle, the immune cells of the spleen, and possibly liver. Both 
kidneys and heart showed no induction of lysosome activity following cold 
exposure. These observations support our overarching model that lysosomes are 
part of a conserved mechanism to generate heat.  
 
Likewise, this inclusive model, unlike the current exclusive definition of 
nonshivering thermogenesis, may explain our peculiar observation regarding 
poikilotherms. As animals without well-functioning cellular pathways that 
regulate body temperature, poikilotherms often rely on behavioral adaptations, 
i.e., moving from an area of one temperature to an area of another temperature. 
Intriguingly, poikilotherms have evolved to survive with turbulent, constantly 
fluctuating internal body temperatures as a result of a highly adaptable set of 
enzymes that can function across a range of temperatures, unlike those of 
homeotherms. Other adaptations may exist that have yet to be described. We 
believe one such adaptation could be lysosomal related. Our data establishing a 
correlation between lysosomal gene transcription and cold exposure in 
poikilotherms support this possibility. As such, this evolutionarily conserved 
phenomenon further points to the crucial nature of lysosomes in body 
temperature homeostasis. 
 
Body temperature regulation and thermogenesis are not limited to the context of 
cold challenge. The phenomenon of febrile response is currently explained by 
vasodilation and BAT activation. However, this rather constrained explanation 
fails to accommodate fever induction in UCP1 deficient mice (Okamatsu-Ogura 
et al. 2007). Given our model, we tested whether lysosomes may be one of the 
missing players. Our LPS and Poly(I:C) injections support this proposal. Both 
fever-inducing agents activate lysosomal gene transcription, protein expression, 
 
 97 
and lysosomal acid lipase activity in BAT, the spleen, and perhaps in even liver 
during febrile response.  
 
Additionally, this chapter demonstrated that lysosomes are not only associated 
with, but also functionally required for thermogenic responses. Both 
pharmacological and genetic inhibition of lysosomal function disrupted cold 
tolerance. A BAT specific injection of chloroquine, which accumulates in adipose 
tissue, showed cold sensitivity, while lysosomal acid lipase deficiency resulted in a 
much more severe cold intolerant phenotype. These data indicate the importance 
of full lysosomal function in maintaining body temperature. In further support of 
these observations, fever induction of LPS and poly(I:C) both are blunted in 
chloroquine injected and LIPA deficient mice. Such evidence support our 
hypothesis and suggest that lysosomes, and particularly lysosomal acid lipase, are 




Limitations and concerns.  
 
 
Nonspecific effects.  
Lysosomes are multifunctional organelles. Cold exposure is a major whole body 
stress and may easily indirectly involve lysosomes as a result. While our 
chloroquine and LIPA deficient models suggest that there is causative 
mechanism, general cellular disruptions in an important cellular machinery may 
non-specifically impair key cellular functions. In the case of BAT, this could 
involve UCP1 uncoupling. However, in our studies of Lipa- deficient mice we did 
not observe any gross derangements to BAT, nor is acute chloroquine treatment 
known to cause broad non-specific impairment in cellular functions.  
 
Cell specificity.  
The observed lysosomal induction with thermogenesis is specific to certain 
tissues. However, these tissues, including the liver, spleen and the brown adipose 
tissue, are heterogeneous, with a number of cell types. This heterogeneity 
prevents us from understanding the true source of the lysosomal phenotype. 
Unfortunately, isolating the various cell populations within these tissue types 
adds an additional confounding variable. Isolation protocols are time consuming 
and require digestions, centrifugation, and various other handlings. Additional 
phenotypes could be added, while others could be lost, making both negative and 































Eight hour cold challenge leads to an increase in LAMP1 protein expression in 
BAT. Immunoblot of LAMP1 and b-ACTIN in BAT after eight hours in the cold. RT: room 












Eighteen hour cold challenge leads to an increase in LAMP1 protein expression in 
BAT. Immunoblot of LAMP1 and b-ACTIN in BAT after 18 hours in the cold. RT: room 












72 hour cold challenge leads to an increase in expression of various lysosomal 
associated proteins in BAT. Immunoblot of LAMP2, LIPA, LAMP1, a-TUBULIN and b-






















Increased LAMP1 expression in BAT tissue sections after cold exposure. 
Immunofluorescence of DAPI (nucleus), LAMP1 (lysosomes), and PLIN1 (lipid droplets) 
in BAT frozen tissue sections after 8, 18, or 72 hrs in either room temperature or cold. 



































Eight hour cold challenge does not alter LAMP1 protein expression in SUBQ. 
Immunoblot of LAMP1 and b-ACTIN in SUBQ after eight hours in the cold. RT: room 













18 hour cold challenge does not alter LAMP1 protein expression in SUBQ. 
Immunoblot of LAMP1 and b-ACTIN in SUBQ after 18 hours in the cold. RT: room 














72 hour cold challenge leads to an increase in LAMP2 expression in SUBQ. 
Immunoblot of LAMP2, LIPA, LAMP1, a-TUBULIN and b-ACTIN in SUBQ after 72 hours 



















































































Liver LAMP1 protein expression does not change after cold exposure. LAMP1 
immunoblot from liver tissue after cold challenge in wildtype male mice. RT: room 









Spleen LAMP1 protein expression increases after cold exposure. LAMP1 
immunoblot from whole spleen after cold challenge in wildtype male mice. RT: room 











Increased immune cell markers in the spleen after cold challenge. Quantitative real 
time PCR of various immune cell markers in the spleen after cold challenge. RT: room 











Cd11b+, LS+ cells are more likely to be F4/80+ after cold exposure. Flow cytometry 
data of Cd11b+, LS+, and F4/80+ cells from splenocyte isolation after cold challenge. 
 Top: Room temperature exposed male mice; Bottom: Cold challenged male littermates. 







Quantification of gating strategies from Figure 2.37. Flow cytometry data of Cd11b+, 
LS+, and F4/80+ cells from splenocyte isolation after cold challenge. Top: Room 








Decreased immune cell markers in spleen of LIPA KO mice after cold challenge 
compared wildtype siblings. Quantitative real-time PCR of various immune cell 
markers of whole spleens from LIPA WT and KO littermates after cold challenge. WT: 




























BAT LAMP1 protein expression after LPS injection. LAMP1 immunoblot from whole 
BAT depots after LPS injection in wildtype male mice. RT: room temperature exposed 








Spleen LAMP1 protein expression after LPS injection. LAMP1 immunoblot from 
whole spleen depots after cold challenge and LPS injection in wildtype male mice. RT: 























































BAT histology of wildtype and LIPA deficient cold challenged mice. H&E staining of 
BAT sections after cold challenge in wildtype and LIPA deficient male mice. RT: room 











Immunofluorescence of wildtype and LIPA deficient cold challenged mice. 
Immunofluorescent staining of BAT sections after cold challenge in wildtype and LIPA 
deficient male mice of LAMP2, M6PR, and COXIV. WT: wildtype male littermates; KO: 









Summary model. Drosophila, liver, spleen, white adipose tissue, brown adipose tissue, 
and muscle all show evidence of association with lysosomes during cold challenge. Both 
brown adipose tissue and the spleen are additionally associated with lysosomes during 
fever induction. Causative experiments disrupting lysosome function either 
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The previous chapter established that thermogenic stimuli induce lysosome 
activity and impairment of lysosomal function reduces body temperature in 
animal challenged with cold and febrile stimuli. However, it is unclear how 
impairment of lysosome function reduces thermoregulation in mice. We propose 
three possible mechanisms: 1) Signaling function of lysosomes regulate known 
thermogenic signals and uncoupled oxidation in BAT; 2) Lysosomes provide 
substrates for uncoupled oxidation in BAT; 3) Lysosomes function as 
thermogenic organelles, generating heat directly.  
 
In this chapter, we will explore the effects of altered lysosomal function on 
canonical pathways that regulate BAT thermogenesis. Previous studies have 
shown that the master transcriptional regulator of lysosomes, TFEB, is also 
involved in the regulation of lipid catabolism in part through PGC1𝛼 (Settembre, 
De Cegli, et al. 2013), itself a transcriptional regulator of mitochondrial function. 
In this chapter, we will explore how cold challenges affect the lysosomal signaling 
machinery and whether impairments in lysosomal function alter canonical 
thermogenic pathways. If lysosomal-dependent signal is critical for these 
pathways, we predict a cold challenge will induce TFEB activation in turn 
causing PGC1𝛼 binding to the promoter of Ucp1, allowing for the critical 




Finally, this chapter will explore other questions regarding the molecular 
signaling mechanisms involved in our lysosome phenotype. If downstream 
pathways such as NST and lysosomal lipid catabolism transcription are altered, 
then upstream regulation and stimulation of NST and lysosomal action may be 
altered in our LIPA deficient model. Examination of these activators, such as 𝛽3-
AR initiation and fasting will be studied.  
 
Proposed Hypothesis and Model 
Lysosomes regulate thermogenic responses by brown adipocytes through the 





Methods and Materials 
 
 
Animals and Animal Care.  
FVB/NJ mice were obtained from the Jackson Laboratory at 6-7 weeks of age, or 
from the laboratory stock of lysosomal acid lipase (LIPA) mice, originally 
generously provided by Hong Du, PhD of Indiana University. LIPA knockout 
mice are missing exon 5 of the LIPA gene, resulting in a dysfunctional LIPA 
transcript. Experiments were performed on littermates. Mice were housed in 
ventilated Plexiglas cages within specific pathogen-free barrier facility maintained 
in a 12-hour light/12-hour dark cycle. Regular water and chow diet were 
provided ad libitum. LIPA deficient mice were genotyped using polymerase chain 
reaction screening of tail DNA. All procedures were approved by the Columbia 
University International Animal Care and Use Committee. 
 
Quantitative Real-time Polymerase Chain Reaction. 
Tissue samples were immediately frozen by liquid nitrogen from euthanized mice 
at the termination of experiments. RNA was extracted from frozen tissue samples 
using an acid-phenol reagent according to manufacturer’s instructions (RNA-solv 
reagent, Omega Bio-tek). RNA was further purified by silica-membrane method 
from the manufacturer (E.Z.N.A. Total RNA Kit II, Omega Bio-tek) and then 
used as template for cDNA synthesis (qScript cDNA SuperMix, Quanta 
Biosciences). Quantitative real time PCR (qRT), was performed using white 384 
well plates in the Roche LightCycler 480 machine. Analysis was done by 
normalizing expression to Rps3 and expressed in relative units using the DDCT-2 
method, taking account of each primer efficiency calculated per in-run standard 





Tissue samples were homogenized by sterile stainless steel beads with QIAGEN’s 
TissueLyser LT in tissue lysis buffer (Tissue extraction reagent I, Thermo Fisher) 
treated with protease and phosphatase inhibitors (Protease inhibitor cocktail I, 
phosphatase inhibitor cocktail II and III, SIgma Aldrich). Protein concentrations 
were determined by standard BCA assay (Bio-Rad). Crude protein extracts were 
centrifuged to separate the lipid fraction from the aqueous layer three times to 
purify protein. Purified protein extracts were gel electrophoresed using 10% 
SDS/PAGE gels, transferred to PVDF .2 um membranes (Millipore), and 
immunostained according to standard methods. Antibodies used: UCP1 (Abcam), 
LAMP1 (eBiosciences), LAMP2 (Abcam), PGC1 (Santa Cruz Antibodies), 
PPARy (Cell Signaling Technologies), phospho-p38MAPK (Cell Signaling 
Technologies), p38MAPK (Cell Signaling Technologies), b-actin (Sigma-Aldrich), 
a-tubulin (Santa Cruz Antibodies). Blots were visualized using LI-COR 
fluorescent secondary antibodies and a Li-COR imager. 
 
Protein densitometry.  
Protein densitometry was calculated using ImageJ. All protein are normalized to 
either beta-actin or alpha-tubulin for whole cell or cytoplasmic fractions. TATA-
binding protein (TBP) (Abcam) was used as the control protein for nuclear 
fractions. 
 
Lysosomal acid lipase activity assay.  
LIPA activity was determined using a 4-methylumbelliferyl oleate assay with 4-
methyumbelliferone serving as the standard curve. 4-MUO was dissolved in 
hexane at 100 mg/ml and diluted 1 to 250 in 4% Triton X-100. Tissue extracts 
were prepared in the same way as western blot samples (see Immunoblots). 25 ul 
of diluted tissue extracts, 50 ul of diluted 4-MUO substrate, and 125 ul of assay 
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buffer (0.2 M NaOAc and 0.01% Tween 80, pH 5) were incubated at 37flC for 30 
minutes. To stop the reaction, 100 ul of 0.75 M Tris, pH 8.0 was added to each 
sample. Fluorescence was detected using (look up machine) at excitation 360 
nm and emission 460 nm. Relative fluorescence units from each sample were then 
compared to that of the standard curve and normalized to wildtype controls. 
 
 
Histology, Immunohistochemistry, and Immunofluorescence.  
Histology was performed by Columbia University Medical Center Russ Berrie’s 
Pathology Core. Sections were sliced at 5um and paraffin-embedded. For IHC 
staining, adipose tissues were fixed with Z-FIX for 48 hours and embedded in 
paraffin. Tissue sections (5mm thick) were deparaffinized, rehydrated, and 
followed by antigen retrieval step before being stained with ABC/DAB 
(Vectastain) kit followed by counterstain. Antibodies used for IHCs: UCP1 
(Abcam). For IF staining, adipose tissues were fixed in 4% PFA for 24 hours, 
followed by 10% sucrose and embedded in OCT before freezing. Tissue sections 
(5mm thick) followed the standard IF protocol described by AbCam. IF slides 
were mounted using Invitrogen’s ProLong Gold antifade reagent with DAPI 
(Invitrogen). Antibodies used: LAMP1 (eBiosciences), LAMP2 (Abcam), PLIN1 
(Abcam), and M6PR (Abcam). 
 
Chloroquine injections.  
Chloroquine (Chloroquine diphosphate salt, Sigma-Aldrich) was dissolved in 
sterile water at a concentration of 100 nM. 100 uL of 100 nM chloroquine was 
injected subcutaneously in the interscapular region of mice. Littermate controls 
were injected with 100 uL of sterile water. Mice were rested for two hours before 




Cold challenge.  
Mice were housed individually for up to 72 hours in 4-8flC. Cold challenge 
experiments for this chapter allowed ad libitum access to regular chow diet and 
water. Mice followed the same 12 hr day/12 hr night cycle of the Columbia ICM 
specific pathogen free housing.  
 
In vivo temperature monitoring.  
To measure the core body temperature of mice during cold challenge, mice were 
placed on wire lids and tails lifted to expose the anal region. Once exposed, a 
rectal temperature probe was inserted to determine internal body temperature. 
Temperatures were recorded after initial equilibration (approximately 4-7 
seconds).  
 
Food intake.  
Food intake was measured by recording weights of food hoppers with food prior 
to cold challenge and post cold challenge. 
 
Statistics. 
Significance calculations of comparisons between two groups were determined by 
student’s t-test. Significance calculations of multiple group comparisons were 
determined first by ANOVA and then Bonferroni correction. Key for all 
significance indications: * = p-value ≤ 0.05; ** = p-value ≤ 0.01; *** = p-value ≤ 
0.001.  
 
Figures represent one experiment out of four. Data are not combined to produce 






Chloroquine injections in cold challenge mice increase thermogenic 
signaling 
We found that chloroquine (CQ) impairs thermogenic response to a cold or 
febrile challenge (Figures 2.47-2.49). A known effect of inhibiting lysosome 
acidification and function is a compensatory upregulation of lysosomal transcripts 
and protein production. Indeed, we found that chloroquine treatment induced 
lysosomal transcripts and LIPA activity in BAT (Fig 3.1-3.2), indicating that our 
injection of CQ into BAT had inhibited lysosome function. We hypothesized that 
impaired lysosome function would reduce thermogenesis via the canonical 
uncoupled program in BAT. This mechanism would predict CQ induced 
reduction in expression of NST-associated genes typically upregulated during a 
cold challenge. Surprisingly, however, we found that the NST associated genes, 
Cidea, Pgc1𝛼, Ppar𝛼, and Ucp1 (Figure 3.1) were upregulated in BAT. SUBQ 
also saw an increase in two NST associated genes, Cidea and Ucp1 (Figure 3.2). 
These data suggest an attempted compensatory increase in canonical NST 
thermogenesis in BAT and that CQ-induced cold sensitivity is not a result of 
impaired thermogenic signaling. 
 
Thermogenic transcriptional programs in brown and beige adipocytes 
of LIPA KO mice. 
Given the thermogenic impairment of LIPA deficient mice, we were curious to see 
whether canonical NST signaling was affected by long-term impairment of 
lysosomal function. Lipa-/- and control littermate mice were exposed to 4-8 C for 
72 hours. We assessed the expression of genes implicated in regulating uncoupled 
mitochondrial oxidation. Unlike CQ treatment, LIPA deficiency did reduce the 
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BAT expression of several transcripts implicated in canonical NST, including 
Pgc1𝛼 and Ucp1 (Figure 3.6). These gene expression data were corroborated by 
immunoblots of PGC1, PPARɣ, and UCP1 (Figure 3.7 and 3.8). These 
observations suggest that lack of LIPA does impair NST signaling in brown 
adipocytes.  
 
Our pharmacologic and genetic data provide somewhat conflicting evidence for 
the role of lysosomes in the canonical NST UCP1 transcriptional program. The 
life long deficiency in LIPA reduced the expression of the NST program while 
short-term inhibition of lysosomes did not. In mice, SUBQ fat contains both 
typical white adipocytes as well as a population of thermogenic cells, beige 
adipocytes (Giralt and Villarroya 2013; Harms and Seale 2013). When a mouse is 
cold challenged, adrenergic and local signal active the classic UCP1 thermogenic 
program in beige adipocytes. Indeed, the induction of UCP1 is typically an order 
of magnitude greater in subcutaneous compared to brown adipose tissue. If LIPA 
deficiency were incompatible generally with the canonical NST signaling, we 
would expect a reduction in the expression of the genes in this pathway. We 
assessed the canonical transcriptional program in SUBQ following a cold 
challenge of 4-8 C for 72 hours.  
 
Unlike BAT, lack of LIPA in SUBQ fat had higher expression of genes that form 
the canonical NST program (Fig 3.9). These included augmented levels of Pgc1𝛼 
and Ucp1 expression. Further validating these data, we found heightened PGC1, 
PPARɣ, and UCP1 protein levels (Fig 3.10, 3.11). Finally, immunohistochemistry 
of sectioned SUBQ tissue display more UCP1 staining in LIPA KO mice cold 
challenged mice compared to their wildtype control counterparts (Figure 3.12). 
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These data, contrary to what was observed in the BAT of LIPA KO mice, 
indicate that NST is not only intact, but also enhanced in the SUBQ of LIPA 
KO mice.  
 
Upstream regulators of nonshivering thermogenesis signaling is 
enhanced in both brown and subcutaneous adipose tissue 
In various models in which we inhibit lysosomal function, we observed apparent 
compensatory effects, with hyperactivation of lysosomal programs in BAT (CQ 
treated animals) and SUBQ (CQ treated & Lipa-/- animals). We searched for 
evidence that signaling upstream of the canonical NST program is upregulated.  
 
NST initiation in the brown adipocyte begins with the activation of the 𝛽3-
adrenergic receptor (𝛽3AR). Following its activation, a signaling cascade begins, 
eventually resulting in the phosphorylation of p38-MAPK, the upstream 
regulator that is necessary for the actions of PGC1𝛼 as well as a number of 
additional proteins and transcription factors crucial in the induction of 
thermogenesis (Tseng et al. 2010). As p38-MAPK is one of the last cytoplasmic 
proteins in the pathway before transcriptional regulation of NST begins, we 
measured phosphorylation of p38-MAPK as an indicator of an intact central 
regulatory system. We found an increase in phospho-p38-MAPK levels in our 
LIPA deficient mouse models compared to their wildtype littermates (Fig 3.13 
and 3.14). Our data argue that the defect in BAT thermogenic signaling is not 
due to decreased upstream signal; rather, there is increased upstream signaling 




Master regulators of lysosomal biogenesis and lipid catabolism are 
not activated during a cold challenge in wildtype mice.  
As seen previously, a cold challenge activates a lysosome transcriptional program 
in select tissues of mice. Lysosomal regulation is primarily dependent on TFEB 
and the related proteins, TFE3 and MITF (Mony, Benjamin, and O’Rourke 
2016; Settembre, Fraldi, et al. 2013; Ploper and De Robertis 2015; Sardiello et al. 
2009). These transcription factors interact with the lysosome via the LYNUS 
machinery. Their sequestration by mTORC1 prevents translocation to the 
nucleus and transcription of the lysosomal program. Initial cold challenge 
experiments indicate an increase in the expression of Tfeb in cold challenged 
wildtype mice and other lysosomal genes controlled by TFEB (Fig 3.15).  
 
To determine whether a cold challenge activates the lysosome transcriptional 
program via the LYNUS machinery and TFEB translocation, we measured 
protein localization and how it was affected by a cold challenge. BAT from room 
temperature and cold challenged mice were extracted from wildtype and LIPA 
knockout mice. Tissues were then processed to two fractions: cytoplasmic and 
nucleic. We quantified TFEB protein in the nuclear and cytosol using standard 
immunoblotting techniques.  
 
Our study of wildtype mice showed that the lysosomal transcriptional program 
was not activated by translocation of TFEB to the nucleus. (Figure 3.16 and 
3.17). The lack of translocation differences between room temperature and cold 
challenged BAT samples suggest that TFEB, and other currently known 
lysosomal and lipid catabolism transcription factors cannot explain either the 
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lysosomal transcriptional program or the NST signaling regulation in wildtype 
mice. 
 
Master regulators of lysosomal biogenesis and lipid catabolism are 
partially impaired in the brown adipose tissue of LIPA KO mice. 
Our gene expression studies of BAT from LIPA-deficient mice reveal lysosomal 
biogenesis and lipid catabolism genes are reduced in the BAT of LIPA KO mice 
(Figure 3.18). We therefore examined TFEB, TFE3, MITF, and MAX protein 
data in subcellular fractions of cold challenged versus room temperature LIPA 
deficient BAT.  
 
We found little expression of TFE3 and MITF in BAT, again suggesting that 
these two proteins are unlikely to play critical role in regulating lysosomal 
biogenesis. However, our TFEB western blots suggest that translocation may be 
blunted in the knockout mice (Figure 3.19 and 3.20). TFEB is both a 
transcriptional regulator of lysosomal function as well as lipid catabolism genes, 
in particular PGC1𝛼. As a result, our LIPA deficient model may have defects in 
lipid catabolism and lysosome function due problems in TFEB translocation.  
 
β-3 adrenergic receptor stimulation requires fasting to activate a 
lysosomal program. 
Cold challenge activates several pathways and systems in homeotherms. The best 
studied and one required for thermogenesis is adrenergic stimulation of BAT. 
Adipocytes, including brown adipocytes, express the 𝛽3-adrenergic receptor 
(𝛽3AR) which is sufficient to activate the canonical thermogenic program of 
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BAT. Therefore, to determine whether 𝛽3AR stimulation alone is sufficient to 
initiate a lysosomal response, we treated mice with the 𝛽3-adrenergic receptor 
agonist, CL-316,243 (CL). Surprisingly, CL treatment alone was insufficient to 
activate Both mRNA and protein data show that 𝛽3AR stimulation alone fail to 
induce a lysosomal phenotype in the BAT and only modestly increased Ucp1 
expression. However, when fasting is combined with 𝛽3AR stimulation, we saw a 
significant induction of a lysosomal phenotype and expression of Ucp1 (Fig 3.21). 
LIPA activity of BAT was similarly regulated, ie only the combination of fasting 
and 𝛽3AR stimulation induced LIPA activity (Fig 3.22). These data suggest that 
cold challenge mimics both a negative energy balance and 𝛽3AR stimulated 
states.  
 
Proposed summary model  
The data presented in this chapter suggest that pharmacologic inhibition of 
lysosomal function in a way that reduces thermogenesis but does not impair 
canonical NST signaling. The effects of genetic inhibition of lysosome function are 
more complex. LIPA deficiency does reduce the UCP1 dependent transcriptional 
response to a cold challenge modestly (˜ 50%) in BAT but not in SUBQ fat. 
Together these data argue that lysosomal function is not absolutely required for a 
canonical thermogenic response. However, it also suggests that LIPA activity 
modulates at least in the thermogenic response in BAT.  
 
Our data also suggest that the signaling upstream of the classical NST response 
is intact when lysosomal function is impaired. Specifically, the canonical 𝛽3-
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adrenergic receptor activated pathway is intact up to p38-MAPK 
phosphorylation, which is upregulated when the contribution of lysosomal 
thermogenesis is reduced in LIPA-deficient or CQ treated mice.  Therefore, this 
observation indicates not only a functional central response, but also a largely 
intact intracellular initial signaling response in the brown/beige adipocyte.  
 
The coordinated upregulation of lysosomal genes in response to a cold challenged 
lead us to hypothesize that placing mice at 4˚C would induce TFEB nuclear 
translocation in BAT. Unexpectedly, we did not observed the expected cold-
induced nuclear translocation. These findings suggest another mechanism by 











In our previous chapter, we were able to demonstrate the importance of 
lysosomal acid lipase in the maintenance of body temperature. Those 
observations did not show how LIPA may be related to temperature regulation. 
Here, our experiments suggest that LIPA deficiency may alter thermogenic 
response by directly signaling to downstream effectors of the NST pathway.  
 
The canonical NST pathway requires the expression of Ucp1 via PGC1𝛼 
activation. The brown adipose tissue of cold challenged LIPA KO mice showed 
impairments in UCP1, PGC1𝛼, PPAR𝛼 at both RNA and protein levels. The 
approximate 50% reduction in expression suggest that lysosomes may be 
transcriptionally involved in altering NST regulation. Of course, these disruptions 
may be a sign of overall cellular dysphoria from LIPA dysfunction. However, two 
observations put these doubts to rest: first, we show in chapter two that the 
gross morphologies of the BAT of LIPA KO mice are normal; second, when we 
look further upstream in the NST pathway, we find compensatory mechanisms to 
account for the NST disruption. As such, our data propose that the NST 
impairment in our LIPA KO mice is a result of LIPA deficiency itself. 
 
Interestingly, while NST was impaired in the BAT of our LIPA KO mice, we 
found the opposite to be true in the SubQ of the same individuals. Instead, the 
white adipose tissue, another source of some thermogenic adipocytes, increased 
the transcription and thusly protein levels of the same NST genes: Ucp1 and 
Pgc1𝛼. Immunohistochemistry of SubQ sections showed a robust increase in 
UCP1 staining. Similar suggestions of differential molecular pathways governing 
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thermogenic adipocytes in SubQ and BAT can be found in chapter two, where 
lysosomes were associated with cold challenge in BAT, but not SubQ. 
 
Disruptions in downstream NST signaling may be explained in part by either 
inadequate cold sensing or activation. However, when we examined the 
phosphorylation of the upstream protein, p38-MAPK, we found that 
phosphorylation was increased in the BAT of LIPA KO cold challenged mice. 
This suggests a compensatory mechanism for the impaired NST response, 
indicating that central regulation is unlikely disrupted. 
 
As part of our hypothesized model, TFEB may exert its actions on NST signaling 
via transcription of Pgc1𝛼, a classic lipid catabolism gene and a known 
downstream target of TFEB. However, cold challenge data of wildtype mice 
demonstrate that TFEB does not translocate during cold challenge. Further 
examination of other members of the family, TFE3 and MITF, yielded 
unsatisfactory answers due to limitations in the antibodies. Nonetheless, we found 
that these master regulators of lysosomal biogenesis and lipid catabolism are 
partially impaired in the brown adipose tissue of LIPA KO mice. Further, other 
lysosomal biogenesis genes and proteins are decreased in LIPA knockout mice 
during cold challenge. 
 
Finally our data suggest that the lysosomal phenotype during cold challenge is 
attributed to not only adrenergic stimulation but also catabolic stimuli, 




Limitations and Concerns 
 
 
Tissue specificity.  
The signaling data presented in this chapter are based off of our whole body 
knockout of LIPA. Therefore, all our data must be interpreted in the whole body 
context. Nonetheless, even in the ideal situation where our studies can be 
conducted in an inducible, tissue specific ablation of LIPA, lysosomal enzymes 
can be secreted and taken up by other cell types. Bone marrow transplantation of 
wildtype into knockout mice and vice versa result in LIPA in nearly all tissues, 
rescuing the severe lipodystrophic phenotype and hepatosplenomegaly in 
knockout mice. In fact, the basis of enzyme replacement therapy for lysosomal 
storage disease patients is dependent on the uptake of lysosomal enzymes in cells. 
While this phenomenon is certainly fortunate for those patients, it provides an 
extra barrier for research studies as an inducible, temporally controlled, tissue 
specific knockout would likely be no different than a wildtype sibling outside of 
their genetics.  
 
Cell type.  
Similar to the limitation already mentioned in the previous chapter, another 
major drawback to this study is the lack of distinction among cell population 
types within the tissues. This heterogeneity may have masked some of the effects 
that we could have seen in brown adipose tissue. 
 
Technical.  
The discoveries of TFEB, TFE3, MITF, MAX, are relatively recent. It is unclear 
what their expression levels are in the various tissues in our mice, particularly as 
the majority of studies have been performed in the liver. While we had a 
functional TFEB antibody, the nonspecific bands of our immunoblots overlapped 
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with TFE3 and MITF, making it difficult to distinguish the differences among 
the various transcription factors. Moreover, both TFE3 and MITF antibodies 
proved troublesome, and we found that interpretation of the data to be 
impossible.  
 
Other transcription factors.  
Given the nonspecific nature of the TFEB antibody, it is possible that other 
transcription factors outside of TFE3 and MITF may be in play. The 
understanding of the lysosomal signaling pathway is still in its nascent stages, 
and the characterization as well as elucidation of other potential transcription 
factors bridging lysosomal function with transcriptional regulation is beyond the 












  n = 6. 
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Figure 3.2  
 
 





Figure 3.3  
 
 





Figure 3.4  
 
 





Figure 3.5  
 
 





Figure 3.6  
 
 

















Densitometry of NST associated proteins. Densitometry of PPARy, PGC1a, and 
UCP1 proteins. WT: wildtype male littermates, HET: heterozygous male littermates, KO: 





Figure 3.9  
 








LIPA deficient mice show increased expression of NST associated proteins in 
BAT. Immunoblots of three key NST-associated proteins: PGC1a, UCP1, and PPARy. 
WT: wildtype male littermates; HET: heterozygous male littermates; KO: LIPA deficient 
male littermates.  
 
 





Densitometry of NST associated proteins in SUBQ. Densitometry of PPARy, PGC1a, 
and UCP1 proteins. WT: wildtype male littermates, HET: heterozygous male littermates, 



















LIPA deficient mice show increased expression of p38MAPK in BAT. Immunoblots 
of phospho-p38 MAPK, p38MAPK and b-ACTIN. WT: wildtype male littermates; HET: 










Densitometry of phospho-p38 MAPK and p38 MAPK in SUBQ. Densitometry of 
phospho-p38 MAPK and p38 MAPK proteins. Pp38:tp38 ratio represents the 
densitometry ratio between phosphor-p38 MAPK and total p38 MAPK. WT: wildtype 
















































LIPA deficiency blunts BAT TFEB translocation in the cold. Immunoblot of TFEB, 
TBP, and b-actin in BAT of wildtype and LIPA knockout males after cold challenge. WT: 
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In the previous chapters, we found that thermogenic stimuli induce lysosome 
biogenesis in a tissue specific manner and that lysosome function is necessary for 
the full thermogenic response of mice to cold or febrile challenges. How lysosomes 
contribute to thermogenesis was not apparent from our initial experiments. We 
tested whether impairment of lysosome function altered canonical thermogenic 
signaling finding both inconsistent and modest results. In addition, the cold and 
LPS-induced lysosomal program was induced in nonUCP1 expressing tissue. This 
suggested another role for lysosomes in the thermogenic response.  
 
As noted in the introduction, degradation of complex biomolecules will generate 
heat if there is catabolism of high energy bond but no capture of the energy. In 
our hypothesized model, lysosomes contribute directly to nonshivering 
thermogenesis as thermogenic organelles. Furthermore, beyond the heat 
generated from catabolic reactions, the acidification of the lysosome via V-
ATPase requires the continual hydrolysis of ATP to ADP. By some calculations 
as much as 60% of the energy from this hydrolysis is released as heat. Moreover, 
any leak in this proton gradient would produce heat in manner similar to SERCA 
or UCP1.  
 
The tools to directly test the ability of lysosomes to directly generate heat do not 
yet exist; here, we have attempted to develop techniques by which we could 
directly and quantitatively measure the heat generated by a cells. If successful, 
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these techniques would lay the foundations for methods to measure heat 
generated by organelles. We studied two methods: infrared thermography and 
isothermal microcalorimetry/isothermal titration calorimetry.  
 
The least sensitive method for measure heat generation involves detection of 
infrared via a camera. Infrared tools measures and converts emissions of the 
infrared wavelength to quantifiable temperature readings. Infrared energy is 
emitted and absorbed by all objects as the molecules change their rotational-
vibrational movements. The thermal radiation measured by infrared detection 
can thus be used as a surrogate for surface temperature. Infrared has been used 
for in vivo models of BAT thermogenic output (C. Jang et al. 2014; Crane et al. 
2014; McCoard et al. 2014). While we attempted to use this same technology for 
ex vivo and in vivo experiments, we found that IR lacked accuracy, precision, 
and sensitivity.  
 
Another method, isothermal microcalorimetry (ITC) proved more robust and less 
susceptible to environmental effects and could measure quantitatively the heat 
generated by suspensions of cells. Isothermal microcalorimetry (IMC) is a 
powerful method that allows for real-time monitoring and analysis of chemical, 
physical, and biological reactions (Koenigbauer et al. 1992; Willson et al. 1995; 
Charlebois, Daniels, and Lewis 2003; Lewis, Gladius, and (Dan) Daniels 2003). 
IMCs have been used to determine prokaryotic and eukaryotic cell growth and 
count in medium (Monti 1990a; Braissant et al. 2010/1; Rodríguez et al. 2011); 
we chose to use this same type of technology to measure heat production from 
our cells. As a form of IMC, we used an isothermal titration calorimetry (ITC) 
system as our primary instrument. This type of microcalorimetry is specifically 
designed to determine the thermodynamics of reactions within a solution. Most 
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often used to study binding affinity, enthalpy changes, and binding stoichiometry 
in biochemical reactions, it tends to be more sensitive than other IMC systems 
and is well suited for our studies due to its application for thermodynamics 
(Pierce, Raman, and Nall 1999).  
 
The central principle governing ITC technology is dependent on detecting 
temperature differences between two “cells” (not to be confused with the 
biological definition of the word). Within the instrument, there is a reference and 
a sample cell composed of thermally conducting and chemically inert material. 
The reference cell is filled with water while the sample cell contains a solution 
generally containing a macromolecule for binding studies. A power is 
continuously applied to the reference cell to heat the cell at a predetermined, 
specified temperature. Simultaneously, a feedback circuit also activates a heater 
in the sample cell. When a titrant is added into the sample cell at specific 
volumes, the reaction within the cell will either be exothermic or endothermic. 
Heat will hence either be released or taken up, causing the feedback circuit 
applied to the sample cell to be either decreased or increased to maintain an 
isothermality between the reference and sample cell (Fig 4.1). The amount of 
input power per unit of time to maintain equal temperatures is measured and 
plotted. The resulting figure should resemble that of Figure 4.2 for our ex vivo 
and in vitro experiments. 
 
Using these calorimetric techniques, this chapter explores not only novel methods 
of studying thermogenesis in cells but also the potential thermogenic nature of 
lysosomes using indirect approaches to alter lysosomal function. 
 
Hypothesis and proposed model: 
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Methods and Materials 
 
Isothermal titration calorimetry. 
ITC measurements were performed on two instruments, Malvern’s VP-ITC 
(courtesy of the Schramm lab at Albert Einstein College of Medicine) as well as 
Malvern’s Auto-ITC200. Reference cells were filled with degassed water, while 
the sample cells were filled with cell medium. The ITC syringes were loaded with 
cell medium and isolated cells in single cell suspension, degassed for 20 minutes 
prior to loading. Parameters of the ITCs were as follows: Two injections, jacket 
temperature of 36 C, stirring speed of 200 rpm. Reference power was set at 15 for 
the VP-ITC instrument but at 5 for the Auto-ITC200. Due to the difference in 
volume capacities, injection volumes for the VP-ITC machine were: 8 ul, 200 ul 
(unless otherwise specified) while the injections volume for the Auto-ITC200 
were: 3ul, 35 ul. Raw data in the form of uCal/sec and time were collected and 
plotted in Graphpad’s Prism software. Change in power were determined by 
taking the difference of averages of ten time points prior and ten points post the 
second injection. This change compared between the control and experimental 
group and significance was determined using the standard student t-test. 
 
Brown adipose tissue isolation. 
Brown adipocytes were isolated from extracted whole interscapular brown 
adipose tissue. Tissue were minced such that individual pieces were ¡1 mm or less 
in diameter in 350 ul of cell medium, resulting in a tissue slurry. Following 
mincing, the tissue slurry was placed in cell medium with liberase (Roche) and 
incubated at 37C with shaking for 30-50 minutes, depending on the efficiency of 
the liberase stock. The resulting solution was passed through a 100 micron cell 
strainer (Gibson) and centrifuged at 500g for 10 minutes. The supernatant was 
removed and the cells were reconstituted in 5 mLs of cell medium before being 
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centrifuged again at 500 g for 10 minutes. Cells were then reconstituted in cell 
medium and counted for cell concentration.  
 
Splenocyte isolation. 
Splenocytes were isolated from whole spleens extracted from sacrificed mice. 
Following extraction, splenocytes were placed in a plate containing a 70 micron 
cell strainer immersed in cell medium. A 10 mL syringe plunger was used to press 
the whole spleen within the cell strainer against the plate wall. After filtering the 
ground tissue through the cell strainer, cells were centrifuged at 500g for 5 
minutes. Following centrifugation, cells incubated in a lysis buffer for five 
minutes at room temperature (Invitrogen) to lyse the erythrocytes. The 
suspension was then pelleted again via centrifugation at 500g for an additional 5 
minutes before resuspending again in two mLs of cell medium. Cells were counted 
for concentration prior to ITC measurements. 
 
Chloroquine injections.  
Chloroquine (Sigma-Aldrich), a lysosome inhibitor, was injected either 
interperitoneally or directly into the BAT tissue at 3.5 mg/kg.  
 
CL 316,243 injections. 
CL-316,243 (Sigma-Aldrich), a beta3-adrenergic receptor agonist, was injected 
interperitoneally at 1 mg/kg. Mice were sacrificed 2 hours post injection. 
 
Chloroquine ex vivo treatment.  
Chloroquine (Chloroquine diphosphate salt, Sigma-Aldrich) was dissolved in 
sterile water at a concentration of 100 nM. 100 uL of 100 nM chloroquine was 
injected subcutaneously in the interscapular region of mice. Littermate controls 
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were injected with 100 uL of sterile water. Mice were rested for two hours before 
subsequent procedures were performed. 
 
Statistics. 
Significance calculations of comparisons between two groups were determined by 
student’s t-test. Significance calculations of multiple group comparisons were 
determined first by ANOVA and then Bonferroni correction. Key for all 
significance indications: * = p-value ≤ 0.05; ** = p-value ≤ 0.01; *** = p-value ≤ 
0.001.  
 
Figures represent one experiment out of four. Data are not combined to produce 







Isothermal calorimetry can be used to measure heat production by 
primary cells. 
To assess the contribution of lysosome function to thermogenesis and confirm 
that alterations, we sought methods to quantitatively measure heat generated by 
cells. In our first attempts to quantitatively measure heat generation, we used an 
infrared camera in a manner similar to what others had done (Lee et al. 2014; 
Christina Jang et al. 2014). However, we found it inadequate in several ways: (1) 
Infrared cameras measure surface temperature and therefore are affected by 
ambient temperature and airflow; (2) the surface temperature of a well 
containing cells is also dependent upon the number of cells and the geometry of 
where the cells sit in the well; and (3) edge effect dissipation greatly confounded 
our readings. 
 
An alternative approach is to measure the heat generated by a closed chamber 
using isothermal titration calorimetry (ITC), a form of isothermal 
microcalorimetry. ITCs are used primarily for binding assays, measuring enthalpy 
of interactions in solution. ITCs are capable of measuring in the nanocalorie 
range, sensitive enough to make it a potential technique to determine lysosomal 
heat contribution. The similar calorimetric technique, isothermal 
microcalorimetry (IMC), can be used to determine cellular growth and decay 
overtime (Monti 1990b; Rodríguez et al. 2011; Braissant et al. 2010/1). ITCs 
have not been shown to work with cellular biology applications.  
 
To assess the applicability of ITCs for our experiments, we first used the 
technique to measure cellular heat production and gradually increased cellular 
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concentration within the sample ampoule. We reasoned that if ITC would be 
useful than there should be a linear relationship between the number of cells and 
heat generated. To test this we measured heat produced by 1x103, 2x104, 2x105, 
and 1x106 splenocytes (Fig 4.3 and 4.4). Splenocytes were chosen for the pilot 
procedure due to their ease of isolation. We found that there was a relative linear 
relationship between heat generation (measured power - microcalories/sec) and 
the number of cells (Fig 4.4).  
 
If ITC could measure meaningful changes in heat, we further reasoned that 
adrenergic stimulated BAT should generate measurably more heat than 
nonstimulated cells. We measured heat generated by 2.5 x 105 cells kept at basal 
(medium + PBS) or thermogenic (medium + CL) condition for two hours prior 
to placement in the ITC. At baseline and 37˚C, BAT cells produced 1.7 
picocalories/sec/cell and, upon stimulation with CL, produced 6.0 
picocalories/sec/cell) (Fig 4.5 and 4.6). These data provide, to our knowledge, the 
first direct quantitative measurement of BAT heat production and the effects of 
activation with adrenergic stimulation. Together, these data provide evidence 
that we could quantitatively measuring heat production using ITC.  
 
Heat production by lysosome impaired BAT and nonUCP1 murine 
tissues  
Because our tissue samples were derived from mice already acclimated to room 
temperature, about 5-10˚C below thermoneutrality, sympathetic activation of 
BAT already exists in our UCP1 tissues. We expected that this activation would 
result in higher baseline heat production in BAT compared to non-UCP1 tissues. 
We compared the heat produced by 1x106 cells isolated from BAT and 
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splenocytes. We did indeed find that BAT cells produced approximately 3.1x 
more heat than splenocytes (Fig 4.7 and 4.8).  
 
To test whether impairment of lysosome function would reduce heat generation 
we treated cells with chloroquine (CQ). In wildtype, unstimulated BAT 
chloroquine reduced by 40% heat production (Fig 4.9 and 4.10). Similarly, BAT 
from Lipa-/- mice produced 60% less heat compared to BAT from Lipa+/+ mice 
(Fig 4.11 and 4.12).  
 
While we found differences in the baseline calorimetric readings between wildtype 
or control and LIPA deficient or CQ treated tissue, adrenergic stimulation may 
override any baseline differences. However, we found that adrenergic stimulation 
by CL-316,243 was unable to restore full thermogenic capacity of either LIPA 
KO BAT (Fig 4.13) or CQ injected BAT (Fig 4.14). These findings are consistent 
with the in vivo finding that Lipa-/- suffer from more severe hypothermia than 
CQ treated mice and .support the importance of functional lysosomes in 
thermogenesis. 
 
Impaired lysosomal function reduce thermogenesis in a nonUCP1 
tissue  
The induction of lysosome biogenesis in nonUCP1 tissues in response to cold and 
febrile stimuli suggested that lysosomes may provide an adaptive role in 
maintenance of body temperature. To test directly whether impaired lysosome 
function directly reduces heat production, we measured heat generated by 
splenocytes from wildtype mice treated with PBS or with CQ. Treatment with 
CQ reduced heat production by 21% (Fig 4.15). Similarly, splenocytes from Lipa-
/- mice produced 34% less heat than splenocytes from Lipa+/+ mice (Fig 4.16 
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and 4.17). These findings argue that lysosomes contribute significantly to the 
generation of heat by both UCP1 expressing and non-expressing cells.  
 
Summary and Proposed Model  







The conclusions of this chapter are twofold. First, we established that isothermal 
microcalorimetry, in particular, isothermal titration calorimetry, can be used to 
measure heat production from cells, including brown adipocytes and splenocytes. 
Second, we provide evidence that functioning lysosomes contribute substantially 
to basal and induced thermogenesis in UCP1 expressing and non-expressing 
tissues.  
 
While we had some preliminary data from infrared (IR) technology, we realized 
that IR was limited by a number of factors. First, edge effect altered accuracy. 
Second, IR readings measured surface readings, affecting both accuracy and 
precision. Finally, sensitivity of IR measurements was limited to only 0.1˚F/C. 
Therefore, a better alternative to measure heat production was needed.  
 
To demonstrate the utility of ITCs for thermogenesis-related studies, we 
performed a number of negative and positive control tests. Negative controls 
using only cell medium initially showed that our readings are not artificial. Non-
thermogenic cells were also able to produce modest amounts of heat, which 
increase proportionally with cell number. Additionally, as one would predict, cells 
from BAT produced more heat than cells not dedicated to thermogenesis. We 
further examined differences in heat production from brown adipocytes with and 
without activation by the 𝛽3-adrenergic receptor agonist, CL-316,243. This 
positive control further convinced us of the utility of ITCs. Taken together, these 
data help establish ITC as a method to quantitatively measure cellular heat 




Convinced of the utility of ITC, we used our newly established methods to test 
our hypothesis that lysosomes are thermogenic organelles. Similar to our earlier 
experiments, we used both pharmacologic and genetic approaches to disrupt 
lysosomal function. Both chloroquine treatment and LIPA deficiency resulted in 
decreased heat generation from brown adipocytes. A similar deficit in heat 
production was also found when lysosome function was impaired in adrenergically 
stimulated BAT. Perhaps more intriguingly however, the same approaches 
resulted in a small but statistically significant decrease in basal heat production 
from a “non-thermogenic” cell type, the splenocyte. These data now provide 
functional evidence that the induction of lysosome in response to cold and febrile 
challenges contributes directly to the generation of heat by both UCP1 and non-




Limitations and Concerns 
 
Ex vivo data. 
The ex vivo model we used to explore our thermogenesis has both advantages 
and disadvantages. As the study of temperature regulation is a whole body 
phenomenon, integration of multiple systems is vital to maintain body 
temperature. Studying cells in isolation may therefore over- or under- estimate 
the contribution of any manipulation to the overall maintenance of body 
temperature. However, by isolating primary cells from our mouse models, we 
were able to determine whether alterations in lysosome function had a direct 
effect on thermogenesis independent of any heat exchange processes.  
 
Tissue heterogeneity.  
Again, the heterogeneous nature of our tissues brings questions to our 
interpretation of the data. We do not know, for example, which cells from BAT 
and spleen are responsible for the thermogenic measurements we made with ITC. 
However, the extra steps necessary to fully isolate the adipocytes from this 
fraction would be an additional confounding component that could influence our 
data. Our ultimate goal in this chapter is to demonstrate that lysosomes are 
capable of generating heat, regardless of its tissue or cell of origin. As such, tissue 
heterogeneity may be more a tertiary concern compared other chapters. 
 
Controls.  
While we used both dead cells and cell medium as our negative controls, the ideal 
negative control for our CL-316,243 activation studies would come from UCP1 
ablated tissue. Heat production from UCP1 ablated tissue would also represent 
thermogenesis from a UCP1 independent manner, possibly contributed by 
lysosome action. Unfortunately, we were not able to obtain the UCP1 knockout 
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mice in time for this study and is included in the “Future Directions” section of 
the final chapter to this dissertation.  
 
Indirect data. One of the primary goals of this chapter is to show that lysosomes 
could be thermogenic organelles. Unfortunately, all of our data are indirect, using 
pharmacologic and genetic agents. Although some of this was circumvented by 
using UCP1 negative tissues, other components may still be at play. Both the 
pharmacologic and genetic approaches could change cell populations as well as 
contribute to overall cellular dysfunction. Additionally, in the BAT tissue, 
coupling between the lysosome and the mitchondrion would disguise our data. To 
address this concern, we would ideally isolate lysosomes directly to determine the 
direct heat contribution of the organelle. This is also discussed further in the 
“Future Directions” section of the final chapter. 
 
Technical.  
ITCs require nearly an hour of time to equilibrate and wash prior to 
measurements. This excess hour can severely affect our observed phenotype as 
the container holding our medium with cells is not optimized for cell culture. As 
an ex vivo study, the same limitations discussed in the ex vivo section would only 
be compounded with this delay. Further, because measurements of multiple 
samples can not be measured simultaneously, environmental factors such as 
temperature fluxes, circadian regulation, and human error would be compounded 















Isothermal calorimetry instrumentation setup.
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Schematic of anticipated ITC results. Arrows represent the start of injections. The first 
injection is a small volume and will result in a minor decrease in power input. The hold 
time after the first volume establishes the initial baseline reading. A longer and greater 
volume is injected, resulting in a large decrease in power input. The amount of power 
released by the injectant is determined by the difference in the average power 








Increasing splenocyte number decreases power input to ITC sample cell. ITC 
uCal/sec measurements of isolated splenocytes at increasing concentrations. 
Representative graphs, n=1 per graph. 
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CL-316,243 treatment increases heat production by isolated BAT. Isolated cells 
from BAT depots were treated with either PBS (left) or 100 nM CL-316,243 (right) for two 


















Isolated BAT cells produce more heat than isolated splenocytes. Isolated cells from 








Isolated BAT cells produce more heat than isolated splenocytes. Isolated cells from 










Chloroquine treatment reduces isolate BAT heat production. Isolated cells from 
BAT depots comparing control injected versus CQ injected mice. Baseline: control; CQ: 




















LIPA deficient BAT produce less heat than wildtype counterparts. Isolated cells 
from BAT depots comparing wildtype and LIPA deficient littermates. Left: wildtype 



































n = 5. 
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LIPA deficient splenocytes produce less heat than wildtype counterparts. Isolated 
splenocytes  comparing wildtype and LIPA deficient littermates. Left: splenocytes from 






















Summary model. Lysosomes are thermogenic organelles that contribute to 
overall body heat production through catabolic reactions, hydrolysis of ATP, and 
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In the classic models of NST, cold exposure induces catecholamine release from 
efferent neurons, activating β3-adrenergic receptors on brown and beige 
adipocytes. This activation results in increased uncoupled mitochondrial 
oxidation (Tseng, Cypess, and Kahn 2010). Despite our understanding of the 
activation mechanisms of thermogenesis, questions regarding the cellular 
physiology of NST in the BAT still remain. In particular, free fatty acids (FFAs) 
are presumed to be key substrates for NST (Moriya and Hiroshige 1981; Vincent-
Falquet et al. 1972; Wu et al. 2006; Guerra et al. 1998).  In addition, it has also 
been assumed that free fatty acids used in uncoupled oxidation and 
thermogenesis are derived from neutral lipase-dependent lipolysis of lipid droplets 
from both white and thermogenic adipocytes. In this model, free fatty acids 
(FFA), are stored as triglycerides (TG) in brown, beige, and white adipocytes. 
These NST substrates are mobilized through action of lipid droplet-associated 
lipases without a role for lysosomal acid lipase (Duncan et al. 2007; Cannon and 
Nedergaard 2004; Virtanen 2014).  
 
In response to catecholamine activation, FFAs derived from the white adipose 
tissue (WAT) TG are released into the circulation and taken up by the BAT; 
while FFAs from intracellular lipid droplet stores of brown and beige adipocytes 
are also thought to provide intracellular substrates for uncoupled oxidation. 
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Current models posit that TG lipid droplets in these adipocytes are mobilized 
through actions of the neutral lipase, including the critical adipose triglyceride 
lipase (ATGL/PNPLA2)  (Duncan et al. 2007; Cannon and Nedergaard 2004; 
Virtanen 2014).  
 
The cold intolerant phenotype of our LIPA deficient model suggests that LIPA 
may also provide FFAs to the mitochondria during cold challenge. To estimate 
the contribution, if any, of LIPA to lipolysis in thermoregulation at 4˚C, we 
compared LIPA deficiency with other lipase deficiencies. The data presented in 




Hypothesis and Proposed Model 
Lysosomal acid lipase is upregulated during cold exposure in order to provide the 





Methods and Materials 
 
 
Quantitative Real-time Polymerase Chain Reaction.  
Tissue samples were immediately frozen by liquid nitrogen from euthanized mice 
at the termination of experiments. RNA was extracted from frozen tissue samples 
using an acid-phenol reagent according to manufacturer’s instructions (RNA-solv 
reagent, Omega Bio-tek). RNA was further purified by silica-membrane method 
from the manufacturer (E.Z.N.A. Total RNA Kit II, Omega Bio-tek) and then 
used as template for cDNA synthesis (qScript cDNA SuperMix, Quanta 
Biosciences). Quantitative real time PCR (qRT), was performed using white 384 
well plates in the Roche LightCycler 480 machine. Analysis was done by 
normalizing expression to Rps3 and expressed in relative units using the DDCT-2 
method, taking account of each primer efficiency calculated per in-run standard 
curve. Primer sequences are listed in Table 1.  
 
Lysosomal acid lipase activity assay.  
LIPA activity was determined using a 4-methylumbelliferyl oleate assay with 4-
methyumbelliferone serving as the standard curve. 4-MUO was dissolved in 
hexane at 100 mg/ml and diluted 1 to 250 in 4% Triton X-100. Tissue extracts 
were prepared in the same way as western blot samples (see Immunoblots). 25 ul 
of diluted tissue extracts, 50 ul of diluted 4-MUO substrate, and 125 ul of assay 
buffer (0.2 M NaOAc and 0.01% Tween 80, pH 5) were incubated at 37flC for 30 
minutes. To stop the reaction, 100 ul of 0.75 M Tris, pH 8.0 was added to each 
sample. Fluorescence was detected using (look up machine) at excitation 360 nm 
and emission 460 nm. Relative fluorescence units from each sample were then 





Ucp1 Cre mice were obtained commercially from Jackson Labs. Atgl fl/fl mice 
were provided from Dr. Erin Kershaw (University of Pittsburgh). Pompe mice 
were gifted by Jeffrey Pessin (Albert Einstein College of Medicine). 
 
Cold challenge. 
Mice were housed individually for up to 72 hours in 4-8flC. Cold challenge 
experiments for this chapter allowed ad libitum access to regular chow diet and 
water. Mice followed the same 12 hr day/12 hr night cycle of the Columbia ICM 
specific pathogen free housing. 
 
Statistics. 
Significance calculations of comparisons between two groups were determined by 
student’s t-test. Significance calculations of multiple group comparisons were 
determined first by ANOVA and then Bonferroni correction. Key for all 
significance indications: * = p-value ≤ 0.05; ** = p-value ≤ 0.01; *** = p-value ≤ 
0.001.  
 
Figures represent one experiment out of four. Data are not combined to produce 








Pompe mice are cold tolerant and increase LIPA activity upon cold 
exposure 
Our data suggest that lysosomal function is necessary for the full thermogenic 
response of mice to a cold challenge. We chose to study LIPA-deficient animals, 
because lipid catabolism has been implicated in thermogenesis previously and 
LIPA expression and activity are induced in by cold challenge in BAT and other 
tissues. To test whether lysosome dysfunction generally impairs thermogenesis we 
studied a mouse model of Pompe Disease. Pompe mice lack acid alpha-
glucosidase (GAA), an enzyme necessary for the breakdown of glycogen in the 
lysosome. As a reflection of the importance of glycogen in muscle, Pompe mice 
exhibit severe muscle pathology, including weakness and atrophy (Bijvoet et al. 
1998; Vellodi 2005). Although effects of GAA deficiency in adipose tissue have 
not been well studied, we did not note any change in Gaa expression in muscle or 
adipose tissue following a cold challenge.  
 
Pompe mice were cold challenged compared with age and sex matched littermate 
control mice. Temperatures were monitored every two hours for 12 hours at 4˚C 
using a rectal probe thermometer (Fig 5.1). We found no differences in body 
temperature in Pompe compared to wildtype controls, demonstrating that 
impairment of lysosome function per se is not sufficient to compromise 
thermogenesis.  
 
Intriguingly, while the Pompe mice were cold tolerant, we found an increase in 
LIPA activity in BAT at 4C (Fig 5.2). We found no changes in other lipases 




Ucp1 Cre, Atgl fl/fl mice are cold tolerant. 
Two groups (Zechner and Sul) reported that deficiency of ATGL/PNPLA2 
causes cold intolerance (Haemmerle et al. 2006; Ahmadian et al. 2011). Mice with 
whole body deficiency were found to die within hours of being placed at 4˚C. 
However, subsequent studies have shown that cardiac specific Atgl expression in 
otherwise deficient mice prevents the cold intolerance. These data argue that 
neutral lipolysis of TG from fat is not necessary for thermoregulation. The cause 
of death of mice completely deficient in Atgl is thought to be secondary to the 
hearts of these mice being unable to tolerate the high sympathetic tone of a cold 
challenge. The Sul group, however, reported that Atgl deletion driven by the 
Fabp4/aP2 promoter leads to modest cold intolerance. Although the goal was to 
direct deletion in adipocytes, Fabp4 is expressed in other cells as well including 
macrophages and some areas of the brain. To address the question of whether 
neutral lipolysis in adipocytes is required for NST, we used an Adiponectin-Cre 
line of mice to provide specific deletion in all adipocytes and a Ucp1-Cre line of 
mice to specifically delete Atgl in thermogenic adipocytes. Mice lacking with 
impaired neutral lipolysis in adipocytes (Fig 5.3) or in brown/beige adipocytes 
(Fig 5.4) were cold tolerant and had no difference in body temperature compared 
to littermate control mice.  
 
Ucp1 Cre, Atgl fl/fl mice show induction of lysosomal program in 
the brown adipose tissue compared to wildtype littermate controls. 
While we established that ATGL is not necessary for thermogenesis in brown and 
beige adipocytes, we sought to determine whether deletion caused any 
compensatory changes in other lipases. Using qRT-PCR, we measured expression 
of the genes, Lipa, Hsl, and Mgl (Fig 5.5). These data demonstrate that Lipa, 
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Hsl, but not Mgl mRNA are upregulated in response to the ablation of Atgl, 
suggesting that other lipases are likely upregulated in response to the lack of 
ATGL in the tissue. 
 
Because our interest is primarily with the lysosome, we further validated the 
importance of various lysosomal genes in Ucp1 Cre, Atgl fl/fl mice. QRT-PCR 
showed that several lysosomal gene transcripts are upregulated during cold 
challenge in Ucp1-Cre; Atgl fl/fl mice (Fig 5.6). LIPA activity was also 
augmented under these conditions (Fig 5.7). These data show that lysosomes are 
increased when ATGL function is disrupted in thermogenic tissues.  
 
Proposed summary model (Fig 5.8). 
Cold tolerance of Pompe mice indicate that glycogen is not necessary for 
thermogenic response and supports the specificity of LIPA activity during cold 
challenge. Data presented in this chapter demonstrate the primary neutral lipase, 
ATGL, is dispensable for NST. However, the increase in expression of other 
lipase suggests that there is compensation and imply a contribution for ATGL in 
generating substrates for NST. The upregulation in expression of Lipa also 
provides indirect evidence that LIPA has a role in providing FFAs for NST, 







Based on the data from this chapter, we see potential evidence supporting the 
contribution of LIPA in contributing substrates needed for nonshivering 
thermogenesis. Published data on HSL and data in this chapter on the Ucp1 Cre, 
Atgl fl/fl indicate that these neutral lipases are not necessary in BAT during cold 
challenge contrary to current dogma. Moreover, LIPA activity and the lysosomal 
program in brown adipose tissue is induced in the floxed mice compared to their 
wildtype littermate controls.  
 
One of the main concerns regarding the LIPA mouse model is its nonspecific 
effects on lysosome function overall. When we examined the cold tolerance of 
another lysosomal storage disease model however, the Pompe mouse, we found 
that those mice were able to survive cold challenge and also increased LIPA 
activity upon cold exposure. Without substrates from food intake, the severity of 
cold intolerance in the LIPA KO mice was further exacerbated. Taken together, 
these data suggest a particular specific importance of LIPA in cold challenge that 
may be a result of its function in producing FFAs from lipids. 
 
Further hints supporting the substrate hypothesis model come from the effect of 
nutritional status on cold survivability outcomes. Our various feeding patterns 
showed that LIPA deficient mice needed to be fed at the start of cold challenge 
to survive (data not shown). We hypothesize that the feeding may alleviate the 
substrate load on the lysosome, allowing for other substrate sources to be used by 
the BAT. This conjecture would rationalize how fasting prior to cold challenge 
would increase lysosomal activity, in particular, LIPA activity during cold 
exposure. Additionally, in Chapter three we found that fasting is required for a 
lysosomal program after pharmacological induction of NST by CL-316,243. While 
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these data do not definitely show that LIPA is necessary in providing substrates, 
they point to the importance of substrate provision with respect to lysosomes 





Limitations and Concerns 
 
Indirect data.  
The majority of the data presented in this chapter are indirect and require 
assumptions to interpret. For instance, our Ucp1 Cre, Atgl fl/fl model genetically 
ablates Atgl function in UCP1 expressing tissues, but does not take account of 
free fatty acid species from other sources. As current research studies, as well as 
this dissertation, have validated the importance of neutral lipase action in white 
adipose tissue (WAT), it is possible that WAT-derived FFAs compensating for 
the ATGL inadequacy in BAT of the Ucp1 Cre, Atgl fl/fl mice. Further, while 
we did notice an increase of LIPA activity in both the Ucp1 Cre, Atgl fl/fl mice 
and the Pompe mice, it is not clear how much contribution LIPA is making to 
the overall FFA pool used by the mitochondria during cold challenge.  
 
Our fasting and refeeding studies show a clear effect on survivability in LIPA 
mice. However, this merely supports, but not prove, the substrate provision 
model. The chow diet fed to our mice is approximately 2-3% fat; by far, the 
majority of the energy consumed by the mice is in the form of glucose and 
carbohydrates. Glucose is important in muscle and somewhat in BAT. However, 
heat generation from shivering is the critical in cold survivability in the first few 
hours of a cold challenge. By not measuring the shivering activity in our mice, it 














n = 6. 
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Figure 5.5: Cold challenged Ucp1 Cre, Atgl fl/fl increase 











Figure 5.6: Cold challenge increases transcription of certain 










Figure 5.7: LIPA activity increases in cold challenged Ucp1 Cre, 
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Lysosomes play critical roles in immune responses, protection from degenerative 
diseases and aging, and metabolic function of cells. Our studies here have 
uncovered a previously unappreciated role for lysosomes in the generation of 
heat. When challenged by a drop in ambient temperature or by pro-febrile 
stimuli, mammals activate thermogenesis to either maintain or increase body 
temperature. We initially observed that in response to these thermogenic stimuli, 
mice increase lysosomal programs in multiple tissue. Even fly larvae activate a 
lysosomal transcriptional program in response to a cold challenge. Disruption of 
lysosome function either pharmacologically via chloroquine administration or 
from ablation of lysosomal acid lipase reduces body temperature during a cold 
challenge and fever induction. These findings strongly implicate lysosomes in the 
generation of heat and body temperature regulation. 
 
To study the function of lysosomes in regulated thermogenesis, we employed 
pharmacologic and genetic approaches, uncovering a complex set of responses to 
impaired lysosomal function. Inhibition by both means lowered body temperature 
and induced varying degrees of compensatory increase in the canonical UCP1 
thermogenic program. Chloroquine impairment in lysosome function led to an 
increase in UCP1 in both subcutaneous and brown adipose tissue depots, 
suggesting a compensatory attempt to increase thermogenesis via the classical 
pathway. In Lipa-/- mice, there too was an increase in the canonical pathway in 
subcutaneous adipose tissue, again as an apparent compensatory mechanism. 
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Consistent with a compensatory effect, upstream signaling as measured by MAP 
kinase phosphorylation was increased. However, in BAT LIPA deficiency, the 
increase was associated with a modest reduction in the expression of canonical 
thermogenic genes, including a 35% reduction in Ucp1. We conclude that while 
lysosome function is not required for uncoupled thermogenesis program, severe 
impairments in lysosomal lipid catabolism likely reduce the signal required for the 
full program.  
 
The modest and inconsistent effect of lysosome impairment on canonical 
thermogenic program across tissues argued that lysosomes contributed to 
thermogenesis via a different, non-classical mechanism. Given the thermogenic 
reality that degradation of biomolecules with high energy bonds requires release 
of energy, it seems necessary that lysosomes must contribute directly to 
thermogenesis. In addition, lysosomes, like mitochondria and sarcoplasmic 
recticula, generate an ion gradient (H+) in a energy consuming process. 
Approximately 50-60% of the energy released during the hydrolysis of ATP to 
ADP via the V-ATPase pump is in the form of heat. Further, it is possible that 
this acidification process could be uncoupled in a manner similar to what occurs 
in mitochondria and across the sarcoplasmic recticula in other well elucidated 
forms of NST.  
 
Testing this hypothesis requires direct measurement of heat generation by 
lysosomes. We attempted to identify methods to do this and found isothermal 
titration calorimetry (ITC) to be a powerful tool. We established ITC as a 
reliable method to measure heat generation by cells, and as a first step we 
measured heat production from cells in which lysosome function was disrupted. 
BAT cells as well as nonUCP1 expressing splenocytes generate heat that is in 
part dependent upon lysosome function. These data indicate that the reduction in 
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thermogenesis caused by CQ or LIPA deficiency is not limited to brown, beige 
adipocytes, or myocytes. With further development, we hope to be able to 
measure the heat generated by isolated lysosomes.  
 
The traditional model of thermogenesis requires FFA mobilization from WAT 
and BAT sources via the action of neutral lipases, particularly ATGL. However, 
contrary to some published studies using the leaky adipocyte protein 2 (Ap2) Cre 
to drive Atgl disruption in tissues, our Ucp1 Cre, Atgl fl/fl mice showed normal 
thermogenic response to cold exposure. Instead, in these mice, we found an 
increase in LIPA activity. These data support the substrate provision model of 
LIPA. We propose that during cold challenge, LIPA acts as one of the main 
lipases that provide the substrates necessary for maintain the FFA pool for 
thermogenesis.  
 
Our work identifies lysosomes as critical for body temperature homeostasis in 
mice. These studies add a new dimension to the understanding of lysosomes and 
their role in cell and systemic physiology. The mechanisms by which lysosomes 
contribute to regulated thermogenesis still need to be further delineate. However, 
we can make several conclusions: (1) Normal lysosome function is required for full 
thermal responses to cold or febrile stimuli and the alterations in heat generation; 




Additional Future Directions 
 
Chapter Two: Heat production and lysosomes. 
In Chapter Two, we demonstrated in mice that lysosomes are induced in response 
to cold and LPS/poly(I:C) and that impairment of lysosomal function reduces 
body temperature in mice in response to thermogenic stimuli. A more complete 
profile of the lysosomal program induced by these stimuli and the cells 
responsible for them will be critical for delineating the mechanisms that regulate 
lysosomal thermogenesis.  
 
In our efforts to understand the regulation of lysosomes in response to 
thermogenic stimuli, we surveyed multiple mouse organs by qPCR and 
discovered increased expression of lysosomal genes in nonUCP1 tissues. An 
unbiased profile gene expression in these tissues (spleen, skeletal muscle, liver) 
would provide not only a more complete picture of the lysosomal program 
activated by cold and pathogen antigens, but may provide hints to the regulatory 
pathways upstream and any changes in the cell population of responsive tissues. 
Our data in spleen suggest that cold can alter the recruitment as well as the 
profile of cells in tissues such as the spleen.  
 
Our poikilotherm data are derived solely from Drosophila melanogaster larvae in 
their third instar stage. However, our model, if accurate, would predict similar 
responses in other organisms. We did not test cold exposure at other stages or in 
other poikilotherms at significant extent. Cold exposure in C. elegans yielded 
some evidence supporting our Drosophila studies (data not shown). Further 
analyses verifying protein expression and activity in multiple poikilotherms would 
help in corroborating our observations. If, however, we can demonstrate that cold 
induces lysosomes in Drosophila larvae (or any other genetically tractable 
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organism) and we can measure a thermogenic phenotype (e.g. survival, 
developmental rate or temperature) then we would have the opportunity to 
perform screens in search of the genes involved in lysosome dependent 
thermogenesis.  
 
Due to technical difficulties and limits in availability, we were not able to obtain 
UCP1 deficient mice. C57BL/6J Ucp1 -/- mice are known to be able to survive 
cold challenge after a three week acclimation in 18˚C, supposedly through 
shivering thermogenesis. These mice will represent an important opportunity to 
test whether lysosome thermogenesis is necessary for the cold survival in the 
absence of uncoupled oxidation. Potentially, our lysosome phenotype may be 
upregulated in the acclimated mice compared to mice raised in thermoneutrality. 
Examining lysosomal function in these mice would therefore reveal the extent of 
lysosome importance in thermoregulation outside of the traditional ”classical 
nonshivering thermogenesis.” A double mutant lacking UCP1 and normal 
lysosome function, e.g. Lipa deficiency, would allow us to understand the relative 
importance of lysosomes in thermoregulation. 
 
While we tested hyperthermia in the form of pyrexia, other inductions were not 
explored. Increasing environmental temperature to determine if lysosomes are 
actively downregulated would provide additionally support our proposed 
mechanism.  
 
Chapter Three: Lysosomes are upstream regulators of thermogenic 
genes. 
Neither genetic ablation of the critical autophagy gene, Atg7, in adipose tissue 
nor in myf5+ lineage (brown adipocytes and muscle) disrupt cold tolerance 
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(Martinez-Lopez et al. 2013; Singh et al. 2009). Those observations suggest that 
autophagy is insufficient to explain the dependence of thermoregulation on 
lysosomal function, at least not in known thermogenic tissues. We are in the 
process of generating mice that lack Atg7 in thermogenic adipocytes using Ucp1-
Cre and Atg7 fl alleles. This would allow us to confirm that autophagy in BAT is 
not required for thermoregulation.  
 
The discovery of TFEB and its critical role in transcriptional regulation of 
catabolism and lysosome biogenesis was published within the last decade 
(Sardiello et al. 2009). Hence, the study of lysosomes and their transcriptional 
regulation is still in its early stages. Our data, while not conclusive, suggest that 
a factor other than, or in addition to, TFEB is critical for cold-induced 
transcription of lysosomal genes. If, like TFEB, the cold dependent transcription 
factor resides in a complex at the lysosome membrane, then proteomic studies 
examining the lysosome membrane prior and post cold challenge may identify 
candidate TFs that are involved. One potential transcription factor family 
involved in autophagy and metabolism is FOXO (Zhao et al. 2008; Hariharan et 
al. 2010; Ning, Li, and Qiu 2015; Sengupta et al. 2009; Milan et al. 2015; Xu et 
al. 2011; Wang et al. 2016; van der Vos et al. 2012). Future studies should 
consider measure levels of the various FOXOs in BAT of both wildtype as well as 
LIPA KO mice prior and post cold exposure. 
 
In C. elegans studies, MXL-3, (MAX ortholog) prevents HLH-30 (TFEB 
orthologue) transcriptional actions by functioning as a repressor for HLH-30 
downstream target genes, particularly lipases. MAX itself is not affected in 
mammalian cells during starvation; other repressors and inhibitors, still unknown, 
are likely involved in the modulation of TFEB actions (O’Rourke and Gary 
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2013). While we struggled to measure MAX, additional studies in identifying and 
characterizing TFEB modulators may also explain our lysosomal-NST 
relationship. 
 
Our data showed a reduction in PGC1𝛼 expression after cold challenge in our 
LIPA KO mice. Interestingly, PGC1𝛼 is crucial in muscle function (Oliveira et al. 
2004; Leick et al. 2010) and shivering during cold exposure. The whole body 
deficiency and our technical limitations in measuring muscle activity prevented 
us from measuring the contribution of muscle shivering in our phenotype. The 
drop in body temperature in Lipa-/- mice may be explained by lysosomal effects 
on Pgc1𝛼 transcription in muscle. Future studies to measure muscle contraction 
as well as PGC1𝛼 expression may be necessary to discern the various 
contributions to body temperature regulation in other tissues.  
 
Chapter Four: Lysosomes as thermogenic organelles. 
 
Chapter four demonstrated and validated the utility of microcalorimetry in 
measuring thermogenesis of cells. We found that we could quantitatively measure 
heat generated by cells. We hope this proves to be a useful tool in studying 
thermogenesis and metabolism more generally. In the future, we hope to adapt 
the technique to measure the heat generated by organelles. While there will be 
technical challenges as well as hurdles to overcome in interpreting such data, we 





The measurements performed to date, however, have been of heat generated by 
whole cells isolated from whole tissues. This limits our ability to interpret these 
data in two ways: 1) Cellular heterogeneity prevents us from determining the 
relative contribution to thermogenesis of each cell type; 2) The direct 
contribution of lysosomes to thermogenesis can only be inferred by measuring the 
heat generated from cells with intact and impaired lysosomal function. Despite 
these limitations, we are excited that this technique will prove useful in other 
studies of thermogenesis, and we are hopeful that approaches will be developed to 
overcome these limitations.  
 
One immediate use for this technology would be to study BAT from UCP1 
deficient mice. Controversy exist as to whether UCP1-deficient BAT can actually 
generate heat. Cannon and Nedergaard maintain that in the absence of UCP1, 
BAT is not thermogenic and that mice maintain body temperature by shivering. 
The slow acclimation, in their estimate, permits them to develop shivering 
“endurance.” Using the ITC techniques developed here, we could test the 
Cannon-Nedergaard hypothesis directly. BAT can be removed and isolated from 
thermoneutral acclimated UCP1 deficient mice and cold challenged, 18˚C 
acclimated UCP1 deficient mice. Heat production by explanted, isolated BAT 
will therefore differentiate the heat contribution of shivering thermogenesis from 
nonshivering thermogenesis with the ITC methodology established in this 
dissertation. 
 
Chapter Five: Additional roles for the lysosome during thermogenic 
stimuli. 
The final data chapter in this dissertation presents a number of limitations. LIPA 
activity was measured only in Ucp1 Cre, Atgl fl/fl and Pompe mice. While cold 
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challenges were performed on the Pompe mouse, more LSD models should be 
examined. The Pompe mouse primarily affects skeletal muscle and therefore the 
reason Pompe mice are not cold intolerant in the way that Lipa-/- mice are may 
simply reflect that mitochondria in key thermogenic tissues are not significantly 
impaired, nor appropriate for testing lysosome importance in BAT. Other 
potential LSDs to examine include Niemann Pick disease type C1 (NPC1) 
disruption, Danon, or Gaucher. Using these other LSD models will provide a 
better understanding of the effects of lipids or overall lysosome disruption on 
nonshivering thermogenesis. 
 
However, ideally LIPA activity should be assessed in Ucp1 Cre, Hsl fl/fl and 
other models of lysosomal storage disease. Compensatory mechanisms of these 
models also add confounding factors that complicate our model. We would use 
lipid tracing and labeling techniques in the diet during cold challenge to 
understand the fate of lipids. Labeled lipids detected in the lysosome during cold 
challenge versus other potential lipid compartments would suggest preferential 
shuttling of lipids to LIPA versus neutral lipases.  
 
The proposed substrate provision model depends on lysosomes providing lipids to 
the mitochondria. As discussed in the previous section, the mechanism 
responsible for free fatty acid delivery to the michondrion is unknown. Disruption 
of fatty acid oxidation in the mitochondria through carnitine palmitoyltransferase 
I (CPT1) would uncouple fatty acids in mitochondria from its delivery 
mechanism. Further examination of the pathways altered, in particular, 
verification of lysosomal alteration, would add to the understanding of LIPA-






UCP1 independent nonshivering thermogenesis  
Our studies suggest that lysosome catabolism serves as a form nonshivering 
thermogenesis. As noted below, some contend that UCP1 independent 
thermogenesis does not exist (Cannon and Nedergaard 2011; Golozoubova et al. 
2001).  
 
“Nonshivering thermogenesis is fully due to brown adipose tissue activity; 
adaptation corresponds to the recruitment of this tissue...Although all mammals 
respond to injected/infused norepinephrine (noradrenaline) with an increase in 
metabolism, in non-adapted mammals this increase mainly represents the 
response of organs not involved in nonshivering thermogenesis; only the increase 
after adaptation represents nonshivering thermogenesis.” (Cannon and 
Nedergaard, 2011) 
 
This position reflects the interpretation of data from older studies stating that 
measured NST capacity during thermoneutrality after catecholamine 
administration is attributable entirely to UCP1 dependent thermogenesis. 
However, if NST is limited to brown adipose tissue activity and activation of 
UCP1, then the ability for Ucp1 ablated mice to survive in colder temperatures 
without increasing shivering from initial exposure suggests that other factors may 
be at play (Golozoubova et al. 2001). In the original paper, Golozoubova, et. al., 
acclimated wildtype and UCP1-deficient mice for three weeks at 
thermoneutrality, room temperature, and 18 C. When acclimated to 18˚C, the 
Ucp1 ablated mice were able to survive in the cold. The authors claim that this 
consistency in shivering at the start and end of acclimation is proof that no other 
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alternative nonshivering thermogenic pathway could exist. The difference in 
survival with and without cold acclimation is attributed to muscle endurance. 
However, during this acclimation, lysosomal activity may have gradually 
increased, an observation that may not be captured without a priori knowledge. 
As discussed in the “Future Directions” section of this chapter, UCP1 deficient 
mice should be tested for lysosomal activity prior and post 18˚C acclimation.  
 
Ultimately, the classical “nonshivering thermogenesis” defined by Nedegaard, 
Cannon, and other experts in the field may be too limited. Other known 
mechanisms that can increase body temperature such as vasoconstriction and 
piloerection are not considered as part of their definition of NST response 
(Cannon and Nedergaard 2011). Without a priori understanding of lysosomal 
function in NST, our characterization of lysosomes may have been lost in earlier 
studies. This dissertation asserts that lysosomes, whose activity is modifiable (to 
an extent), should be considered as part of the NST definition.  
 
Thermoneutrality and acclimation. 
One of the main lessons learned from Golozoubova, et. al, and other studies from 
both Nedergaard and Cannon is the effect of acclimation on NST research. Our 
experiments were performed on mice that were raised in an ambient temperature 
of 20-25˚C. Assuming that this acclimation has no effect on lysosome activity and 
is purely increasing muscle endurance, then our LIPA KO mice may simply suffer 
from poor muscle endurance (See “Future Experiments.”). However, LIPA 
deficient mice, if fed, exhibit a U-shaped temperature curve. Their body 
temperatures never fully recover, suggesting that shivering alone may not 
describe our cold intolerance phenotype. While these data do not definitively rule 
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out shivering as the sole factor in determining cold survivability of our LIPA 
deficient mice, they do raise doubts in the applicability of the counterargument. 
 
Measuring nonshivering thermogenesis. 
Nedergaard and Cannon have long argued that a cold challenge does not permit 
accurate measurement of NST. Instead, they insist cold challenges primarily 
reflect shivering and often failure to maintain body temperature is a measure of 
exhaustion. Catecholamine injection is the gold standard for inducing BAT and 
measuring its capacity; however, this approach has a myriad of limitations. First, 
as with all pharmacological interventions, catecholamines have a number of 
targets beyond thermogenic adipocytes. Even CL-316,243, a 𝛽3 adrenergic 
receptor-specific agonist activates 𝛽3-adrenergic receptors expressed on the 
bladder (Cypess et al. 2015), gallbladder (Guillaume et al. 1994), and skeletal 
muscle (Chamberlain et al. 1999). Effects on these tissues would therefore be 
expected to overestimate NST attributable to BAT.  
 
Second, catecholamine administration is recommended to be done at 
thermoneutrality to avoid sympathetic activation at lower temperatures (Cannon 
and Nedergaard 2011); however, even thermoneutral conditions can activate 
UCP1 through diet (Hervey and G. 1981). Third, injections often increases stress, 
which alone raises body temperature (through endogenous catecholamines) and 
various other physiological and confounding responses. Lastly, the biggest 
limitation in catecholamine injection to measure NST is that it assumes that 
NST can only be activated by adrenergic means. Our data show that CL-316,243 
administration alone is incapable of increasing the lysosomal transcription we 
discovered in the BAT. This same program however, is activated by cold 
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exposure alone. Norepinephrine may be additionally needed (see “Future 
Experiments’), as it also activates 𝛽1-adrenergic receptor, contributing to NST 
activation. Unfortunately, this agonist targets a myriad of tissues outside of 
BAT. Nonetheless, fasting combined with 𝛽3-adrenergic receptor stimulation was 
required to simulate a similar lysosomal response to cold challenge, suggesting 
that NST may not be equated to adrenergic thermogenesis. 
 
Therefore, the study of NST is limited by the available tools; neither cold 
exposure nor catecholamine activation can accurately describe nor measure NST 
capacity and activity in animals. Chapter four of this dissertation proposes an ex 
vivo method of measuring heat production via ITC or IMC instruments. If 
combined with other measurements, the microcalorimetry approach may allow for 
more accurate study of NST. 
 
Febrile Response . 
While Cannon and Nedergaard argue that uncoupled oxidation is the only source 
of nonshivering thermogenesis in response to a cold challenge, it is clear that heat 
production can occur in the absence of UCP1 and mitochondrial uncoupling. 
Although “shivering” and alterations in blood flow can contribute to the 
development of fever, hypermetabolism in the absence of shivering or shaking 
exists. Given that hypermetabolic febrile responses occur equally in individuals 
with little brown adipose tissue (obese and elderly), in the absence UCP1 and 
shivering (Himms-Hagen and Jean 2009; Gabaldón, McDonald, and Horwitz 
1998; Cypess and Kahn 2010; Okamatsu-Ogura et al. 2007; Lenhardt et al. 1998), 
there likely are nonshivering forms of thermogenesis. We have argued that 
lysosomes play a role in thermogenesis of fever. While critics may argue that our 
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pharmacologic and genetic manipulations impair cold response because of reduced 
muscle function and endurance, the argument is less compelling in the context of 
febrile response experiments.  
 
Physiological responses to hyperthermia. 
While we have framed our study of lysosome catabolism and thermogenesis in the 
context of increasing thermogenesis, our model predicts that  at higher ambient 
temperatures or excessive heat generation, lysosome function may be 
downregulated to reduce lysosome-derived heat. This can be tested by placing 
animals at multiple temperatures and demonstrating an inverse relationship 
between higher ambient temperatures and lower lysosome activity. It may be 
possible that different tissues may alter their lysosomal program through a range 
of temperatures. In this way, lysosomal activity may not only increase during a 
cold challenge, but also decrease during excess heat. 
 
Brown vs. Beige Adipocytes 
Data in Chapters two and three suggest that lysosomal thermogenesis 
differentiates brown from beige adipocytes. We find that lysosomal function is 
induced during a cold challenge and important in brown adipose tissue, whereas 
activation of lysosomal thermogenesis appears to be absent from beige cell 
containing subcutaneous adipose tissue. Previous studies have established 
differences in lineage and transcriptional activation between the two cells (Jun 
Wu et al. 2012; J. Wu et al., n.d.). Our data add to another functional difference 
that distinguishes brown from beige adipocytes.  
 
Other thermogenic pathways. 
The regulation of brown and beige adipocyte thermogenesis in mammals depends 
upon a complex neuroendocrine system in which peripheral sensing of 
 
 256 
temperature are relayed to key nuclei in the hypothalamus that subsequently 
activate autonomic and endocrine signals to modulate thermogenesis. The targets 
for this neuroendocrine regulation include the control of the UCP1 program in 
adipocytes and circulatory responses to maintain temperature homeostasis (Fan 
et al. 2005; Morrison, Madden, and Domenico 2014; Morrison, Kazuhiro, and 
Madden 2008; Guernsey, D.L., and I.S. 1983). Interestingly, while Drosophila is 
not a homeotherm and not known to possess an integrate temperature regulatory 
system, we found that, similar to our studies in mice, a cold challenge induces a 
lysosomal transcriptional program. In addition to arguing that the lysosome’s 
contribution to thermogenesis is evolutionarily ancient, it also suggests that it is 
activated by a system that is different than that which regulates UCP1 
thermogenesis. Others have characterized the “cold shock” response of Drosophila 
demonstrating that at least at the cellular level they respond to cold temperature 
by activating the transcription of proteins that serve to protect the fly (Czajka 
and Lee 1988; Ayar et al. 2010; Moskalev et al. 2015; Burton et al. 1988; Goto 
2001). Consistent with our data, fasting, which induces catabolism and lysosomal 
function, increases cold tolerance in Drosophila (Le Bourg 2015). Recent studies 
from the Spiegelman laboratory found evidence for a cell autonomous system of 
temperature sense in mammalian cells as well, specifically that Myf5 negative, or 
inducible, adipocytes are capable of sensing temperature directly, without the 
need to activate its 𝛽3-adrenergic receptor (Ye et al. 2013). Identification the 
stimuli to cold-induced lysosome biogenesis will help us establish whether there 
are cell autonomous mechanism that contribute to thermogenesis.  
 
Lysosomes and central control of body temperature regulation. 
Work from the Singh lab has identified autophagy in Proopiomelanocortin 
(POMC) neurons (important in regulating anorectic behavior) in the central 
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regulation of temperature response via effects on BAT and the liver (Martinez-
Lopez et al. 2016). Cold exposure increases autophagy in POMC neurons, leading 
to the activation of lipophagy in BAT. Additionally, Martinez-Lopez et. al., 
indicate that this autophagy induction is necessary for lipid mobilization in BAT, 
as the denervation of BAT blocks lipid utilization. Our LIPA deficient mouse 
model may have impaired autophagy in the hypothalamus, which based on these 
data could reduce lipid mobilization in BAT. However, the deletion of Atg7 in 
hypothalamic POMC neurons does not render mice cold intolerant, and we find 
evidence of increased, not reduced, sympathetic signaling in BAT. Furthermore, 
fat-specific deletion of Atg7 does not render mice cold-intolerant. LIPA, therefore, 
has a more central role in thermogenesis. Its phenotype does not appear to be 
attributable to alterations in autophagy, either centrally or peripherally.  
 
Lysosome regulatory pathways.  
As a multifunctional organelle, the lysosome must integrate its functions with 
other cellular systems and processes, including phagocytosis, autophagy, and 
program cell death (Settembre et al. 2013; Ballabio 2016). Currently, only one 
protein, TFEB, has been shown be a master regulator of lysosome biogenesis and 
function. Not surprisingly, TFEB is also an important transcriptional regulator of 
autophagy. In our attempt to identify the regulatory pathway that activates 
lysosome transcription in response to cold, we did not find convincing evidence 
that TFEB or related proteins, TFE3/MITF, played a role. Nor could we find 
evidence for the regulation of the negative regulator of TFEB, MAX in our 
experimental conditions. There are several strategies that can be employed to 
identify key regulatory molecules: 1) Identify transcriptional regulators by 
analyzing complexes associated with the Lipa promoter in BAT upon cold 
challenge; 2) Set up a screen in Drosophila to identify genes that prevent cold-
induced lysosome biogenesis; 3) Perform proteomic analysis of lysosomes isolated 
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from mice a room temperature and following a cold challenge. Each of these 
approaches has limitations, but offer a possible avenue to discover the regulatory 
pathways involved in cold and febrile induced lysosome biogenesis.  
 
Lipid shuttling during thermoregulation. 
Our LIPA deficient model and its cold intolerance questions the current dogma 
that neutral lipases (ATGL, HSL and MGL) provide free fatty acids necessary for 
uncoupled mitochondrial thermogenesis. Atgl-/- mice are cold-intolerant, similar 
to Lipa-/- mice (Ahmadian et al. 2011). However, our data with adipocyte-
specific deletion of Atgl and work of others (Zechner) reveal that death of the 
Atgl-/- mice is not due to adipose tissue deficiency but likely to heart failure 
(Kienesberger et al. 2012). Atgl-/- mice suffer from severe cardiomyopathy and 
typically begin to die around 12 weeks of age. Fat-specific deletion of Atgl does 
not result in a cardiomyopathy (Haemmerle et al. 2006). Cold challenge increases 
heart rate more than twofold compared to thermoneutrality (Institute of 
Medicine (US) Committee on Military Nutrition Research, Marriott, and Carlson 
1996; Blumberg, Sokoloff, and Kirby 1997). Zechner and colleagues now conclude 
that “cold intolerance” of Atgl-/- mice is likely secondary to heart failure. We 
did, however, find increased expression of Lipa in BAT lacking ATGL. Together, 
these data suggest that both neutral lipases and LIPA contribute to the pool of 
fatty acids used for uncoupled oxidation.  
 
Aging. 
One of the most common findings in aging is its association with decreased 
lysosomal and autophagic function. The exact molecular processes engaged are 
unclear; whether lysosomes directly or indirectly modulate longevity, at least in 
humans is unknown. Certainly, the current body of evidence provide intriguing 
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support for lysosomes and longevity. In C. elegans data, overexpression of TFEB 
and a C. elegans lipase connected to TFEB, LIPL-4 can both extend lifespan 
(Lapierre et al. 2011). Studies on caloric restriction and rapamycin have shown 
that activation of autophagy and reduction of mTOR activity improves 
longevity. Impaired CMA in the liver promotes aging, while restoration of its 
function prolongs healthspan (Zhang and Cuervo 2008). These studies point to an 
obvious relationship between functional autophagy, and consequently, lysosomes 
with pathological aging.  
 
Similarly, aging is also correlated with impaired homeothermy in both mice and 
humans (McDonald and Horwitz 1999; Gabaldón, McDonald, and Horwitz 1998; 
Kerckhoffs et al. 1998). Could lysosomal dysfunction explain the impaired 
thermoregulation in aged mammalian models? Current hypotheses attribute cold 
intolerance in aged models to a combination of muscle and BAT atrophy and 
capacity. In the context of our study, we propose that lysosomes promote 
thermogenesis, not only through signaling, but also as a direct thermogenic 
organelle.  
 
Thermoregulation and aging are complex physiological mechanisms. This 
dissertation provides some potential hints toward the theme of aging. Competent 
lysosomal activity may contribute a positive thermoregulatory role to whole body 
physiology. The subsequent metabolic and other physiological responses to proper 
homeothermy may hence prevent pathological aging.  
 




Nonshivering thermogenesis research exploded in the last decade in part due to 
its theoretical potential to increase energy expenditure, independent of lifestyle 
interventions. Previous attempts to increase energy expenditure 
pharmacologically resulted in dangerous, non-specific uncoupling of mitochondria 
and hyperthermia. A more targeted approach of activating thermogenic pathways 
in relevant cells could avoid such problems. However, the relatively low BAT 
mass in adult humans makes the substrate for such activation small. This 
dissertation proposes a new method of inducing thermogenesis that does not 
depend on uncoupling mitochondria. Further, by exploiting this aspect of 
biological energy expenditure via lysosomes in both Ucp1 expressing and negative 
tissues, low BAT mass limitations in humans is no longer a concern.  
 
Despite some evidence that increasing “browning” of adipose tissue in mice 
reduce obesity, the success of such an approach in humans assumes that weight 
regulatory systems will not respond to the increase in energy expenditure. The 
homeostatic systems that regulate fat mass and body weight “defend” adiposity 
by mechanisms that are not well delineated; however, these homeostatic systems 
must somehow not be engaged to increase food intake after “browning.”  
 
Regardless of the benefits of weight loss through lysosomal activity, activating a 
lysosomes directly or indirectly via other areas of the lysosomal pathway may not 
yield in the anticipated weight reduction. For instance, induction of autophagy 
without subsequent activation of lysosomal accommodation may result in cellular 
toxicity. Overexpression of LIPA has additionally lead to disappointing results in 
the context of atherosclerosis (Zschenker, Illies, and Ameis 2006). It is unclear if 
LIPA overexpression yields in any other prometabolic markers. Further, if 
enhancing lysosomal activity, in particular LIPA, increase cellular substrates such 
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as FFAs, but disregard the necessary simultaneous oxidation and processing of 
these substrates, cellular toxicity could still occur. In fact, excess FFAs may 
enhance metabolic dysregulation, exacerbating the very derangement we aim to 
treat.  
 
If activation of a thermogenic pathway does have therapeutic potential, then 
activating lysosomal activity may provide a potential new avenue for treating 
obesity. TFEB, and potentially other transcription factors responsible for both 
lysosomal biogenesis and catabolism, may be useful pharmacological targets. 
With its multiple functions within the cell, it would target both the production as 
well as the processing of lysosomal activity and its subsequent products. A recent 
study in mice demonstrated that, hepatic TFEB overexpression improves 
metabolic profiles. Similar prometabolic phenotypes have been found in 
macrophage specific TFEB overexpression (Emanuel et al. 2014). Such 
observations not only support the data presented here but also demonstrate the 
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